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CHAPTER I
INTRODUCTION
The fluidity of synaptic membranes has been shown
to affect the activities of several membrane-associated
enzymes.

These include Na+K+-ATPase (Farias et al.,

1975; Alivisatos et al., 1977; Sandermann, 1978; Alivisatos
et al., 1981) and adenylate cyclase (Rimon et al., 1978;
Whetten et al., 1983).

Membrane-associated functions of a

number of neurotransmitter systems have also been shown to
be modulated by membrane fluidity.

The neurotransmitter

systems include the serotonergic (Heron et al., 1980a,b;
Heron et al., 1981), opioid peptide (Heron et al., 1980a;
Heron et al., 1981), GABAergic (Toffano et al., 1981; Chweh

& Leslie, 1982; North & Fleischer, 1983b), and cholinergic
(Crews et al., 1983a; Freund et al., 1986) systems.
Postnatal development, aging, and alcoholism are
accompanied by changes in membrane-associated functions of
several neurotransmitter systems (Freund, 1982; Meyer et
al., 1984), an increase in the synaptic membrane cholesterol to phospholipid molar ratio, and decreased membrane
fluidity (Crews et al., 1983b; Lyon & Goldstein, 1983; Nagy
et al., 1983).

It is possible that the changes in neural

function are due, in part, to the changes in synaptic membrane lipid composition and fluidity.
1

2

To study this hypothesis, the influence of cholesterol-induced changes in membrane fluidity on the
dopaminergic system was investigated because the dopaminergic system is sensitive to the effects of aging and
alcohol (Roth, 1982; Hoffman & Tabakoff, 1985).

The cho-

lesterol content of synaptic plasma membranes and synaptosomes was altered using a lipid transfer protein from beef
liver, which accelerates the exchange of cholesterol between liposomes and synaptic membranes.

The fluidity of

control and lipid-modified synaptic plasma membranes (SPM)
was assessed by fluorescence polarization techniques, using
l,6-diphenyl-1,3,5-hexatriene, to probe the hydrophobic
core of the membrane, and l-anilinonaphthalene-8-sulfonic
acid to probe the membrane surface.

Control and lipid-

modified synaptosomes were assayed for [ 3H]-dopamine
uptake, binding to the

o1 receptor as assessed by the

binding of [ 3H]-SCH23390, and maximal stimulation of
adenylate cyclase activity by dopamine.

The results ob-

tained from these studies may provide important information about the influence of synaptic lipid composition and
fluidity on receptor-mediated neural function.

This data

may provide a basis for understanding some of the age- and
alcohol-related changes in neural function.

CHAPTER II
REVEIW OF THE RELATED LITERATURE
MEMBRANE COMPOSITION AND FLUIDITY
FACTORS INFLUENCING MEMBRANE FLUIDITY
The fluidity of a biological membrane relates to
the dynamic physical state of the fatty acyl chains of the
phospholipids comprising that membrane bilayer {Stubbs,
1983).

Factors that influence membrane fluidity include:

the unsaturation and chain length of fatty acids, the
change in frequency of trans-gauche isomerizations of

c-c

bonds of the methylene groups in phospholipid fatty acyl
chains, and the rate and range of motion in phospholipid
fatty acyl chains.

Also important are the lateral and

rotational mobility of phospholipids, changes in phospholipid head group conformations, changes in the interaction
of cholesterol with membrane lipids, and the change in the
interaction of proteins with lipids (Shinitzky & Barenholz,
1978; Houslay & Stanley, 1982; Stubbs, 1983; Stubbs &
Smith, 1984).
The degree of unsaturation and chain length of the
fatty acids (FA) in phospholipids are important in membrane
fluidity.

A decrease in the double bond index:saturated

ratio, defined as:
3

4

/.;

(mole % unsaturated FA X # double bonds)
mole % saturated FA

(eq. 1)

(Stubbs, 1983) has been used as a chemical measure of
membrane fluidity (Farias et al., 1975).

This assumption

is valid when other parameters, such as cholesterol/phospholipid molar ratio (Chol/PL), remain constant and the FA
double bonds have the same cis configuration (Castuma &
Brenner, 1983).

studies using biological membranes indi-

cate that a significant change in the degree of unsaturation of FA results in only small changes in the motion of
the FA chains as measured using electron spin resonance
(ESR) and fluorescence techniques (Stubbs & Smith, 1984).
Phospholipid head groups have a complex effect on
membrane fluidity.

In model membranes, phospholipid bi-

layers prepared from individual classes of saturated phospholipids, the transition temperatures vary from
phosphatidylcholine (PC) membranes to
myelin (SP) membranes.

o0 c in

3o 0 c in sphingo-

It is evident that the head group

influences acyl chain motion, but the biological importance
is unclear because of the variability in the fatty acid
composition between the classes of phospholipids found in
biological membranes (Stubbs, 1983).
Membrane-bound proteins have an immobilizing
effect on the lipids that surround them (boundary lipids)
(Stubbs, 1983).

The fluidity of lipids in the region of

proteins can be studied using nuclear magnetic resonance
(NMR) techniques with deuterated phospholipids.

This is

5

not very efficient, however, because the labelled boundary
lipids readily exchange with bulk lipid.

Because of the

nature of their probes, ESR and fluorescence spcectroscopic
techniques give no information about the fluidity of this
boundary lipid region (Feinstein et al., 1975; Stubbs,
1983).
Cholesterol, a major lipid of plasma membranes of
most cells (Stubbs, 1983), is a principal modulator of membrane fluidity.

With its rigid, planar, wedge-shaped

structure, cholesterol orients perpendicular to the membrane surface, with its hydroxyl group near the carbonyl of
FA (Houslay & Stanley, 1982; Stubbs, 1983) (Figure 1).
Cholesterol has the ability to condense phospholipid
bilayers, making them less permeable to small molecules.
Various physical techniques have demonstrated that cholesterol has a small fluidizing effect below the phase
transition temperature (gel phase), and a large rigidifying
effect above this temperature (Figure 2) (Van Blitterswijk
et al., 1981; Stubbs, 1983).

Cholesterol diminishes the

enthalpy change at phase transition.

The presence of large

amounts of cholesterol in the membrane removes the phase
transition characteristics.

Cholesterol appears to act as

a buff er against large changes in the bulk physical properties of the membrane produced by other agents such as
alcohol (Stubbs, 1983).

In most cases, the viscosity

(inverse of fluidity) of a biological membrane reflects its

6
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Figure 1. Interaction of Cholesterol with PhosphoLipids in a Lipid Bilayer.
(Houslay and Stanley, 1982)
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Figure 2:

The Effect of Cholesterol on Membrane
Phospholipids Above and Below the
Transition Temperature.

The arrows point to cholesterol within the
bilayer.

Above the transition temperature (Tc),

cholesterol will condense phospholipid bilayers,
reducing their permeability to small molecules.
Below the transition temperature, cholesterol
liquifies the bilayer, allowing more freedom of
movement of the fatty acyl side chains.
(VanBlitterswijk et al., 1981)
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Chol/PL, although these cholesterol effects are influenced
by the FA composition of phospholipids and charged groups
at the membrane surface (Feinstein et al., 1975).
TECHNIQUES FOR MEASURING MEMBRANE FLUIDITY
NMR.

In nuclear magnetic resonance (NMR) studies,

deuterated lipids are incorporated into the membranes to be
studied.

Although this method produces the least perturba-

tion of the membrane structure (Stubbs & Smith, 1984), it
has several drawbacks.

The sensitivity is low, expensive

equipment is required, and special deuterated phospholipids
must be synthesized in large quantities.

Also, the assump-

tions used to derive the rate of motion and the calculations are very complex and reportedly less reliable than
those utilized in fluorescence studies (Stubbs, 1983).
ESR.

Electron spin resonance (ESR) of a nitroxide

probe can provide information about the mobility of the
probe, the orientation of the probe in its environment, the
order of the system, and the lateral diffusion of the probe
in the plane of the membrane (Jain & Wagner, 1980).

The

drawbacks of ESR are similar to those of NMR in that the
equipment is expensive and the spin-labelled probes must be
synthesized.

Unlike NMR, ESR probes, because of their

unpaired electron, can perturb the membrane.
FLUORESCENCE POLARIZATION.

Fluorescence polariza-

tion is based on the phenomenon that when a fluorophore is
excited by light, it absorbs the light energy and emits

9

photons of lower energy.

This technique can be adapted to

give information on the orientation or range and rate of
motion of the fluorophore and its adjacent environment
(Bentley et al., 1985).
In order to understand the basic principles of
fluorescence polarization, several phenomena involved in
the fluorescence of a molecule should be described (Bentley
et al., 1985).

First, an interval of time exists between

the absorption and fluorescent emission of light.

This

interval is the fluorescence lifetime and is usually in the
nanosecond range.

Second, the emitted light is not re-

leased in a random direction, but is oriented in a direction determined by the transition moment of the excited
molecules, the direction in which the molecule most easily
absorbs light.

Light is preferentially absorbed when the

electrical vector of the exciting light is parallel to the
transition moment of the molecule.

The electric vector of

the emitted light will also be parallel to the transition
moment of the excited molecule.
When a molecule is excited with polarized light,
the electric vector of the emitted light will be parallel
to the electric vector of the exciting light if the molecule remains stationary during the lifetime of the excited
state (Bentley et al., 1985; Shinitzky & Barenholz, 1978).
Rotation of a molecule during its excited state will depolarize the emitted light with respect to the exciting

10

beam.

As the molecular motion in a system increases, the

emitted light will be increasingly depolarized (Bentley et
al., 1985; Shinitzky & Barenholz, 1978).
Fluorescence polarization values (P) are measured
by exciting a molecule with polarized light and observing
the intensity (I) of the emitted light oriented parallel
and perpendicular to the direction of the electric vector
of the exciting light.

P is calculated by the equation:
( eq.

p ==

2)

1 11 + Ii

(Bentley et al., 1985; Shinitzky & Barenholz, 1978).
Experimentally, polarization measurements are made
by determining the fluorescence intensity reading with the
excitation and emission polarizers in combinations of vertical (v) and horizontal (h) positions.

The possible com-

binations are vv, vh, hh, hv, where the letter order represents the excitation and emission polarizers respectively.

I

1

and Il in equation 2 correspond to the settings vv

and vh respectively.

The hh and hv settings are used to

correct for artifacts introduced by the instrument.

In

practice, P is calculated by the equation:
( eq. 3)
Ivv + Ivh (Ihv/Ihh)
Polarization data can be expressed as polarization
(P) values as described in equations 2 and 3, or as aniso-

11
tropy (r) values:
r =

IiI, - I..1.
I

11

( eq. 4)

+ 2I..1.

(Shinitzky & Barenholz, 1978).
P values can be converted to r values by the
equation:
r

=

2P
( eq. 5)

3-P
(Shinitzky & Barenholz, 1978).
The relative microviscosity of the membrane can be
calculated from the r values by the equation:
1

relative microviscosity =

~~~~-

(eq. 6)

(r 0/r)-l
(Shinitzky & Barneholz, 1978). The term r 0 refers to the
limiting anisotropy and is experimentally determined for
each fluorescent probe.
Barenholz, 1978).

For DPH, r 0 = 0.362 (Shinitzky &

For ANS, r 0 = 0.346 (Weber & Daniel,

1966) •
FLUORESCENT PROBES
DPH.

l,6-Diphenyl-1,3,5-hexatriene (DPH)

(Figure

3a) is a polyene hydrocarbon with a stable all-trans configuration of an elongated rectangular shape (Shinitzky &
Barenholz, 1978).

It partitions easily into membranes,

orienting itself perpendicular to the plane of the membrane
(Stubbs & smith, 1984) (Figure 3c).

DPH does not fluoresce

Figure 3

a) Structure of DPh

b) Structure of ANS

c) Orientation of DPH and ANS in a PhosphoLipid Bilayer.
(Jost and Griffith, 1980)
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in an aqueous environment (Stubbs & Smith, 1984).

Its

quantum yield increases when the environment becomes hydrophobic, and continues to increase as the viscosity increases, approaching 1 (Shinitzky & Barenholz, 1978).

The

excitation and emission maxima (360 nm and 430 nm, respectively)

(Litman & Barenholz, 1982) remain constant, regard-

less of the phase or composition of the membrane (Shinitzky

& Barenholz, 1978).

When cholesterol is incorporated into

a phospholipid bilayer, the DPH polarization values are
greater than those in the absence of cholesterol.

The in-

crease in DPH polarization has been correlated to an increase in Chol/PL (Van Blitterswijk et al., 1984).

These

properties make DPH an almost ideal probe for the hydrophobic region of the membrane (Stubbs & Smith, 1984).
ANS.

l-Anilinonaphthalene-8-sulfonic acid (ANS)

(Figure 3b) is a negatively charged molecule that, in the
membrane, localizes in the region of the phospholipid polar
head, with its aromatic rings at the level of the FA carbonyl, and its sulfonate group directed outward (Figure 3c)
(Slavik, 1982).

The magnitude of the fluorescence signal

from ANS in aqueous solvents is low, but increases as the
solvent becomes less polar.

The probe prefers to interact

with the choline-containing head groups of phosphatidylcholine (PC) and sphingomyelin (SP).

Although the positive

charge of these groups plays a role in the binding of ANS,
the interaction is not entirely electrostatic in nature as
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phosphatidylethanolamine (PE), which is also positively
charged, does not bind ANS.

As the Chol/PL increases

within the membrane, the ANS is pushed closer to the surface of the membrane, which makes it more accessible to the
aqueous environment, and which decreases the quantum yield
(Slavik, 1982).
Although ANS is sensitive to the changes in its
environment near the membrane surface, it also binds noncovalently to proteins within the membrane.

This can make

it difficult to interpret fluorescence polarization data if
it is not properly acquired.

ANS binding to proteins is of

very high affinity, but the number of binding sites is
low.

The excitation and emission maxima are 380 nm and 480

nm, respectively.

The lipid binding sites are of lower

affinity, but are more abundant than those on the proteins.

The excitation and emission maxima for these sites

are 395 nm and 490 nm respectively.

When low concentra-

tions of ANS are used (1 µM), ANS binds primarily to proteins.

At high concentrations (200 µM), the fluorescence

reflects ANS bound predominantly to lipids (Slavik, 1982).
Under the appropriate conditions, ANS can be a useful probe
of the membrane surface.
MEMBRANE FLUIDITY DURING DEVELOPMENT
As the brain develops, the lipid composition of
synaptic plasma membranes (SPM), and hence the fluidity of
SPM, have been observed to undergo a series of alter-
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ations.

Hitzemann (1981) studied the FA in rat cortical

SPM phospholipids as a function of postnatal age (7 days,
14 days, and adult).

Overall, between day 7 postnatal and

adult, there was a trend toward increased polyunsaturated
long chain FA and decreased short chain saturated FA.
cific changes are detailed below.

Spe-

The double bond index-

saturated ratio (equation 1, page 4) increased from day 7
to day 14, followed by a slight decrease from day 14 to
adult.

(Hitzemann & Johnson, 1983).

In PC, the major phos-

pholipid, decreases were observed in 14:0, 16:1, and 22:5
FA, with increases in 18:0, 22:6, and the largest increase
in the ratio of 22:6 to 22:5 (22:6/22:5)

(281%).

In PE,

18:0 increased from day 7 to 14 and decreased from day 14
to adult.

Incr~ases

were also observed in 22:6, 22:4, and

the 22:6/22:5 ratio (104%) associated with PE.

Ethanol-

amine plasmalogen (EP) showed an increase in 22:4, a
decrease in 22:5, and an increase in the 22:6/22:5 ratio.
SP showed a decrease in 16:0 and an increase in 18:0. In
phosphatidylinositol (PI), 16:0 and 18:0 were decreased
while 20:4 was increased.
the opposite trend.
and 22:5.

Phosphatidylserine (PS) showed

Decreases were observed in 20:4, 22:4,

A transient increase in 22:6 was observed along

with increases in 16:0 and 18:0.

Taken alone, these

changes would not be sufficient to produce a significant
change in membrane viscosity.
Further studies of age-related changes in synaptic
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membrane composition during development (Hitzemann &
Johnson, 1983) focused on the observed molar Chol/PL,
protein to lipid ratio, SP content, degree of phospholipid
methylation, and ganglioside content, along with steadystate anisotropy of DPH fluorescence of the intact SPM as
well as bilayers prepared from lipid extracted from these
membranes.

The results of these studies demonstrated an

increase in fluorescence polarization of intact membranes
and lipid bilayers during development, and hence a decrease
in fluidity (increase in viscosity) with age.

The sterol/

phospholipid ratio in adult rats was increased as compared
to both 7 day and 14 day membranes.

These changes would

produce an increase in the viscosity of the membrane.
protein/phospholipid ratio increased after day 14.

The

This

suggested that the fluidity change observed from day 7 to
day 14 was due to changes in the lipid components of the
membrane (Hitzemann & Johnson, 1983).
There is a developmental decrease in choline phospholipids, primarily due to a decrease in PC.

Ganglioside

levels were not changed during development (Hitzemann &
Johnson, 1983).

Thus, it is seen that during development,

the decrease in membrane fluidity is primarily due to
increases in Chol/PL and the protein to lipid ratio, as
well as a decrease in PC.
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MEMBRANE FLUIDITY DURING AGING
In order to maintain the normal function of biological membranes, it is important to maintain the fluidity
of those membranes within a narrow range.

This is referred

to as membrane fluidity homeostasis (Shinitzky, 1984).
This is believed to occur through enzymatic processes which
change the degree of unsaturation of FA in phospholipids
and/or which lead to the esterif ication of excess membrane
cholesterol.

Lipid changes observed in aging have been

suggested to be due to a weakening of the processes which
maintain homeostasis (Shinitzky, 1984).
Early studies of membrane fluidity utilized homogenates of whole brain and brain regions.

With increasing

age, an increase in viscosity was observed in all brain
regions studied (Samuel et al., 1982).

Total protein and

cholesterol were increased in whole brain homogenate
(Calderini et al., 1983) as well as the Chol/PL in homogenates prepared from hippocampus, caudate, and cerebral
cortex (Samuel et al., 1982) from 24 month old rats, as
compared to 3 month old rats.

These studies did not

attempt to correlate whole brain changes with particular
neural membranes, such as SPM or myelin.
Using DPH (Shinitzky et al., 1983; Calderini et
al., 1983) and 16-doxyl stearic acid (Nagy et al., 1983) to
probe the hydrophobic core of the membrane, it was found
that the viscosity of synaptic membranes in aged mice (24-

18
28 months)

(Shinitzky et al., 1983) and rats (24 months)

(Calderini et al., 1983; Nagy et al., 1983) was increased
as compared to that of young animals (2-3 months).

This

increased viscosity was accompanied by an increase in
Chol/PL of up to 30% in aged animals (Shinitzky et al.,
1983; Armbrecht et al., 1983).
It has been suggested (Hitzemann, 1984) that an
incremental increase in cholesterol will have a small effect on membrane viscosity if the membrane normally contains a relatively high amount of cholesterol (Chol/PL =
0.5), as is the case with SPM.

Therefore, additional fac-

tors must be involved in the observed increase in viscosity found in aging.
MEMBRANE FLUIDITY AND ETHANOL
Ethanol, added in vitro, will increase the
fluidity of synaptic membranes as assessed using ESR probes
(Chin & Goldstein, 1977a,b; Chin & Goldstein, 1981;
Goldstein et al., 1982; Armbrecht et al., 1983; Logan et
al., 1983).

Many such studies used high, and non-

physiological ethanol concentrations (up to 500 mM)
(Armbrecht et al., 1983; Logan et al., 1983).

However,

ethanol has demonstrated a fluidizing effect at concentrations as low as 10 mM ethanol (50 mg%)

(Chin &

Goldstein, 1977a) and produced a dose-related change in
fluidity between 10 mM and 350 mM ethanol (Chin &
Goldstein, 1977a).
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Chronic ethanol administration produces a type of
membrane tolerance in synaptic and other cellular membranes.

Although no change in baseline fluidity of the

membranes was observed, in studies using DPH (Beauge et
al., 1984) and 5-doxyl stearic acid (Chin & Goldstein,
1977b) as probes, the membranes from the ethanol-treated
animals were resistant to the fluidizing effects of ethanol
(Chin & Goldstein, 1977b; Johnson et al., 1979; Beauge et
al., 1984).

In addition, using a 12-doxyl stearic acid

probe, which measures the fluidity deeper within the membrane, a decrease in the baseline fluidity was detected in
the interior of membranes from ethanol-treated animals
(Lyon & Goldstein, 1983).

Also, the partition coefficient

of ethanol into synaptosomes from ethanol-treated animals
was 66% lower than into control membranes (Rottenberg et
al., 1981; Rubin & Rottenberg, 1983).
The composition of synaptic membranes from control
and ethanol treated rats and mice has been studied by many
investigators.

The results obtained appear to be dependent

on the method of administration of ethanol, as well as the
duration and dose administered.

Synaptic membranes from

Sprague Dawley rats given intragastric doses of 20% aqueous
ethanol (Crews et al., 1983b), C57/BL6 (Smith & Gerhart,
1982) and DBA/2J (Chin et al., 1978) mice fed liquid diets
containing 7% and 33% ethanol, respectively, were found to
have an increase in the Chol/PL as compared to controls.
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This was due to an increase in cholesterol content (cholesterol/mg protein) with no change in phospholipids.

The

magnitude of the increase in Chol/PL was up to 30% over the
control, which could be considered the physiological limit
of the Chol/PL.

The FA composition of the phospholipids

was not changed by the chronic ethanol administration (Chin
et al., 1978; Smith & Gerhart, 1982; Crews et al., 1983b).
When ethanol was administered to T 0 Swiss mice
by inhalation, different results were obtained (Littleton &
John, 1977; Littleton et al., 1979).

No change in choles-

terol content or Chol/PL was observed.

However, there was

an increase in 18:0 FA and a decrease in 20:4 FA (Littleton

& John, 1977; Littleton et al., 1979), producing a decrease
in the double bond index:saturated ratio (equation 1, page
4).

The discrepancy in the results may be due to the me-

thod of administration of ethanol.

Inhalation may be a

more severe technique, producing and maintaining high
ethanol concentrations in the brain.

It is possible that

alterations in the FA composition can be implemented more
quickly than alterations in cholesterol content.

Use of

liquid diets and intubation produces lower blood and brain
ethanol concentrations.
Both an increase in Chol/PL and a decrease in the
double bond index:saturated ratio could be responsible for
the tolerance observed.
al.

To study this further, Johnson et

(1979) extracted the lipids from synaptic membranes of
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control ICR mice and those treated chronically with ethanol
by intraperitoneal injection.

The lipids were reconsti-

tuted and the fluidity determined using DPH as probe.

The

lipids from the ethanol-treated animals were less fluidized
by ethanol and had a lower intrinsic fluidity than controls.

When cholesterol was removed from the reconstituted

lipids, the change in fluidity in response to in vitro
ethanol was indistinguishable in the ethanol-treated and
control groups.

When cholesterol was added to the recon-

stituted lipids so that the Chol/PL of the lipids from the
control and ethanol-treated groups were equal, the difference in response to in vitro ethanol returned, although
there was no difference in the intrinsic fluidity of the
reconstituted lipids.

This study suggests that cholesterol

is involved in tolerance, but is not solely responsible for
it (Johnson et al., 1979).
DOPAMINE BINDING
DOPAMINE RECEPTOR SUBTYPES
There appears to be some disagreement in the literature as to the number of dopamine receptor subtypes
present in rat brain.

Seeman & List (1981) describe four

receptor subtypes based on their affinities for dopamine
(an agonist) and spiperone (an antagonist).

D1 recep-

tors, localized postsynaptically, have a low affinity for
dopamine and spiperone (3000 nM and 2000 nM respectively)
and are linked to the stimulation of adenlyate cyclase.
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o2

receptors, also localized postsynaptically, have a low

affinity for dopamine (5000 nM) but a high affinity for
spiperone (0.3 nM).

The

o2

receptors are thought to be

responsible for the behavioral effects of neuroleptic
drugs.

D3 receptors, found both pre- and postsynaptic-

ally, have a high affinity for dopamine (3 nM) but a low
affinity for spiperone (1500 nM).

o4 receptors, possibly

localized postsynaptically, have a high affinity for both
dopamine and spiperone (20 nM and 0.1 nM respectively) and
are linked to dopamine-inhibition of adenylate cyclase activity.

The existence of the D3 and

types is disputed by Creese et al.

o 4 receptor sub-

(1983), who suggest that

the D3 and D4 receptors are high agonist-affinity
states of the D1 and D2 receptors, respectively.
MEASURING DOPAMINE BINDING PARAMETERS
Several ligands are presently available to study
dopamine receptors.

The most widely used is spiroperidol

(spiperone), a dopamine antagonist.

Spiperone, at nano-

molar concentrations, is known to bind to serotonin as well
as dopamine receptors (Creese et al., 1977; Creese &
Snyder, 1978).

In bovine caudate (Creese et al., 1977) and

rat striatum (Hamblin et al., 1984), where the density of
serotonin sites is low, spiperone binds primarily to dopamine sites.

Because the D1 receptor has a much lower

affinity for spiperone than does the D2 receptor, binding
studies utilizing low spiperone concentrations will detect
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primarily the higher affinity o 2 sites (Hamblin et al.,
1984).
and

o2

At higher concentrations, binding to both

the o1

sites is suggested by nonlinear Scatchard plots.
To quantitate the

o2

sites, the

o2 -specific

antagonists, domperidone and sulpiride, have been used
(Hamblin et al., 1984).

Antagonist/[ 3 HJ-domperidone

competition curves suggest the presence of a single o2
dopamine receptor. Whereas, agonist/ [ 3 H]-domperidone
competition curves suggest the presence of high and low
agonist-aff inity states of the

o2

receptor (Hamblin et

al., 1984).
The partial dopamine agonists, apomorphine and
ADTN (2-amino-6,7-dihydroxyl-1,2,3,4-tetrahydronaphthalene)
label both

o 1 and o 2 receptors in rat striatum.

These

ligands stimulate adenylate cyclase through the o 1 receptor.

They are also displaced by low concentrations of

spiperone, characteristic of binding to the o2 receptor
(Creese et al., 1978; Creese & Snyder, 1978b).

Both of

these ligands exhibit decreased binding in the presence of
guanine nucleotides.
The o 1 receptor has been difficult to characterize because of its low affinity for agonists and spiperone
(Seeman & List, 1981).

The first high affinity o1 ligand

to be characterized was cis-flupenthixol, a dopamine
antagonist (Hyttel, 1978; Cross & Owen, 1980; Hyttel, 1980;
Leff et al., 1985).

In the presence of low concentrations
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of spiperone (10 nM) to block binding to n2 receptors,
cis-flupenthixol binding to n1 receptors was studied in
rat striatum (Hyttel, 1978; Hyttel, 1980; Leff et al.,
1985) and bovine caudate membranes (Cross & Owen, 1980).
However, high nonspecific binding (up to 70%) (Leff et al.,
1985), makes cis-flupenthixol a poor choice for a n1
ligand.

n1 receptors are specifically labelled with the

o1 antagonist, SCH23390.

In vitro binding studies reveal

a single class of high affinity sites in rat striatum, with
a Kd of 0.14 nM (Anderson & Nielsen, 1986).

However,

from in vivo studies, the Kd is calculated as 12.3 nM,
which is similar to the Ki for SCH23390 inhibition of
dopamine-sensitive adenylate cyclase in vitro (Anderson &
Nielsen, 1986).

Thus, in the in vitro studies using

SCH-23390 reflect the kinetics involved in the first step
in the activation of dopamine-sensitive adenylate cyclase,
namely, the initial binding to the receptor.
As characterized by domperidone and SCH23390
binding studies, there are two types of dopamine binding
sites, each of which exhibit high and low agonist affinity
states (Hamblin et al., 1984; Hess et al., 1986).

In both

cases, the high affinity form can be converted to the low
affinity form by the interaction with guanine nucleotides
(Hamblin et al., 1984; Seeman et al., 1985; Hess et al.,
1986).

This suggests that both the n1 and D2 receptors
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may be linked to adenylate cyclase, D1 in a stimulatory
capacity and D2 in an inhibitory capacity (Creese et al.,
1983).
DOPAMINE RECEPTORS IN DEVELOPMENT AND AGING
Much of the work done on dopamine binding during
postnatal brain development has used [ 3 H]-spiperone as
ligand (Murrin, 1982; Nomura et al., 1982; Hartley & Seeman, 1983).

Using autoradiography, following intraperit-

oneal injection of [ 3 H]-spiperone, Murrin (1982) demonstrated a dramatic increase in dopamine binding sites in
the striatum of the rat between 5 and 15 days postnatal.
Binding, similar to that found in the adult, was achieved
by 15 days of age.

In vitro binding studies have demon-

strated that [ 3 H]-spiperone binding increases rapidly
from day 5 (Hartley and Seeman, 1983) to a peak at 30 days
of age (Nomura et al., 1982).

Between 30 and 70 days of

age, there is reportedly a small decrease in spiperone
binding (Nomura et al., 1982).
[ 3 H]-Spiperone has also been used to assess
dopamine receptors in studies of aging.

In all studies,

[ 3 H]-spiperone binding was lower in the aged animals (24
to 28 month old rats, and 5.5 year old rabbits) than in
young animals (3 month old rats, and 5 month old rabbits)
(Govoni et al., 1978; Govoni et al., 1980; Memo et al.,
1980; Misra et al., 1980; Thal et al., 1980; DeBlasi &
Mennini, 1982; Trabucchi et al., 1982; Cimino et al., 1983;
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Govoni et al., 1983; Missale et al., 1983).

In general,

the Bmax was 30-50% lower in aged animals (Memo et al.,
1980; Misra et al., 1980; DeBlasi & Mennini, 1982;
Trabucchi et al., 1982; Missale et al., 1983).
Because spiperone binds to both the D1 and

o2

receptors, there is little information available about
which specific receptor subtype is primarily affected by
aging.

However, limited studies using [ 3 H]-domperidone

(Trabucchi et al., 1982; Missale et al., 1983) and [ 3 H]sulpiride, D2 antagonists,

(Memo et al., 1980; Missale et

al., 1983) suggest that the decreased spiperone binding in
aged animals is due to a decrease in the number of D1
receptor sites.

This decrease may be the result of either

a decrease in the number of receptors per cell or a loss of
neuronal synapses, or both (Severson & Finch, 1980).
DOPAMINE RECEPTORS AND ETHANOL
There is disagreement as to the effects of chronic
ethanol consumption on the binding of ( 3 H]-spiperone to
dopamine receptors.

Some investigators find no difference

in Kd or Bmax between control and ethanol-treated animals (Tabakoff & Hoffman, 1979; Rabin et al., 1980).
Others find a small decrease in the Ka for [ 3 H]-spiperone (Barbaccia et al., 1980; Reggiani et al., 1980;
Barbaccia et al., 1982; Lucchi et al., 1983).

In summary,

it appears that chronic ethanol consumption has little
effect on the kinetics of binding to dopamine receptors.
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DOPAMINE-SENSITIVE ADENYLATE CYCLASE
BIOCHEMICAL PROPERTIES
Adenylate cyclase is a membrane-associated enzyme
which catalyzes the conversion of ATP to 3 1 -5 1 cyclic AMP
(cAMP)

(Spiegel et al., 1985).

The cAMP produced then

binds to the regulatory subunit of cAMP-dependent protein
kinase, causing it to dissociate from the catalytic subunit.

The active catalytic subunit of protein kinase

subsequently stimulates the phosphorylation of one or more
cellular proteins (Figure 4).

Adenylate cyclase is activ-

ated by specific hormones and neurotransmitters through a
two-step process (Spiegel et al. 1985).

The unoccupied

receptor interacts with the guanine-nucleotide binding
protein (G-protein) which enhances the affinity of the
receptor for the hormone or neurotransmitter.

When do-

pamine, f9r example, binds to the D1 receptor, GTP binds
to the G-protein, which results in the activation of the
G-protein.

The activated G-protein dissociates from the

receptor and stimulates the catalytic subunit of adenylate
cyclase to form cAMP (Spiegel et al., 1985).

The GTP is

then hydrolyzed to GDP and Pi by the intrinsic GTPase
activity in the G-protein, which causes the G-protein to be
deactivated.

The deactivated G-protein dissociates from

adenylate cyclase and reassociates with the receptor to
complete the cycle (Figure 4)

(Spiegel et al., 1985).

Dopamine-sensitive adenylate cyclase has a

Km
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EXTRACELLULAR
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Figure 4. Schematic Representation of Hormoneand Neurotransmitter-Sensitive Adenylate
Cyclase.
H, R, and G, represent the hormone, receptor, and
guanine nucleotide binding protein, respectively.
The subscripts s and i represent stimulatory and
inhibitory, respectively.
(Speigel et al., 1985)

29
for dopamine of 4-5 µM (Nathanson, 1977; Miller & McDermed, 1979), with maximal stimulation above 50 µM dopamine (Miller & McDermed, 1979).

stimulation by dopamine

is inhibited well by cis-flupenthixol (Enjalbert et al.,
1978: Miller & McDermed, 1979).

Haloperidol is a less

potent inhibitor of adenylate cyclase.

Sulpiride, a D2

antagonist, does not inhibit dopamine stimulation of
adenylate cyclase (Miller & McDermed, 1979).
DOPAMINE-SENSITIVE ADENYLATE CYCLASE DURING DEVELOPMENT AND
AGING
During postnatal development in the rat striatum,
the basal (unstimulated) activity of adenylate cyclase, as
well as the dopamine-stimulated adenylate cyclase activity,
increased from days 1 to 23 (Enjalbert et al., 1978).

Al-

though the amount of cAMP produced upon stimulation by 100
µM dopamine increased as a function of age, the % stimulation decreased from 350% on day 1 to 180% on day 23
(Enjalbert et al., 1978), because of the age-related rise
in the basal activity.
During aging in rabbits (Makman et al., 1980) and
rats (Zimmerman & Berg, 1975; Puri & Volicer, 1977; Schmidt

& Thornberry, 1978), there was no change in the basal
adenylate cyclase activity (Zimmerman & Berg, 1975; Puri &
Volicer, 1977; Schmidt & Thornberry, 1978; Makman et al.,
1980) or that stimulated by NaF, which acts directly on the
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enzyme (Zimmerman & Berg, 1975; Puri & Volicer, 1977).
However, the stimulation of adenylate cyclase by 100 uM
dopamine was decreased in aged (24 to 30 month old) rats
(Puri & Volicer, 1977; Schmidt & Thornberry, 1978) and (5.5
year old) rabbits (Makman et al., 1980) as compared to
adult animals.

This decreased stimulation was observed in

rats at as early as 12 months of age (Puri & Volicer, 1977;
Schmidt & Thornberry, 1978).

By 30 months of age, no

statistically significant stimulation by dopamine was
detected (Puri & Volicer, 1977).

Because there was no

change in basal adenylate cyclase activity, the total
amount of enzyme present was not affected by aging, suggesting that the o1 receptor-containing cells were not
lost.

Therefore, the observed decrease in stimulation may

be due to changes in membrane composition and fluidity.
DOPAMINE-SENSITIVE ADENYLATE CYCLASE AND ETHANOL
Ethanol, added in vitro to membrane preparations,
increased the basal activity of adenylate cyclase (Hoffman
et al., 1983), but had no effect on dopamine stimulation of
adenylate cyclase activity (Hunt et al., 1979).

However,

chronic administration of ethanol produced an increase in
the basal activity (Kuriyama et al., 1977; Lucchi et al.,
1983), with no change in that which was stimulated by NaF
(Kuriyama et al., 1977; Tabakoff & Hoffman, 1979; Lucchi et
al., 1983).

In addition, chronic ethanol treatment pro-

duced a decrease in sensitivity to dopamine (Lucchi et al.,
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1983), which was most evident upon withdrawal (Tabakoff &
Hoffman, 1979).

When ethanol was added in physiological

concentrations to ethanol-tolerant membranes, the dopamine
sensitivity of the adenylate cyclase activity returns to
normal values, suggesting that dopamine sensitive adenylate
cyclase is adapted to physiological ethanol concentrations
in chronic ethanol exposure.

The decreased sensitivity of

the adenylate cyclase to dopamine stimulation was due to a
decrease in the efficiency of coupling between the dopamine
receptor and the adenylate cyclase catalytic site (Tabakoff

& Hoffman, 1979), which could be due, in part, to a change
in membrane composition and fluidity.
DOPAMINE UPTAKE
BIOCHEMICAL PROPERTIES
Dopamine uptake into synaptosomes is an energy dependent, temperature-sensitive process.

This process func-

tions to remove released dopamine from the synaptic cleft,
and hence, to terminate the biological response (Horn,
1979).

The uptake process is dependent on sodium and to a

lesser extent potassium.

Calcium is not required.

At

37°c, the uptake is linear for 5 to 10 minutes and is
proportional to the amount of synaptosomal protein in the
assay mixture (Horn, 1979).

Dopamine uptake is competi-

tively inhibited in vivo (Manias & Taylor, 1983) and in
vitro (Hunt et al., 1974; Horn, 1979) by nomifensine
(8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline)
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which inhibits the accumulation of dopamine in synaptosomes
without stimulating the release of dopamine (Hunt et al.,
1974; Horn, 1979; Manias & Taylor, 1983).

When adminis-

tered in vivo, nomifensine produces a 3-fold increase in
the

Km

for dopamine (Manias & Taylor, 1983).

DOPAMINE UPTAKE DURING DEVELOPMENT AND AGING
Dopamine uptake has been studied during postnatal
development in the rat.

The reuptake of dopamine in new-

born rats was 10% of that in the adult rats (Horn, 1979).
When uptake was determined at 100 nM [ 3 H]-dopamine, there
was a 3-fold increase in uptake (pmole/g wet wt tissue)
from day 6 to day 22 postnatal (Slotkin et al., 1980; Deskin et al., 1981).

Km

Vmax; the

This increase is due to an increase in

was unchanged (Coyle & Campachiaro, 1976).

The changes in dopamine uptake during aging have
been studied in C57BL/6J mice (Jonec & Finch, 1975).

Up-

take into crude synaptosomes at 10 nM [ 3 HJ-dopamine was
30% lower in 28 month old mice than in mature (2-3 month
old) mice.
observed.

Km

At 120 nM [ 3 HJ-dopamine, no difference was
Kinetic analysis revealed a 35% increase in the

for dopamine in old mice as compared to controls.

Vmax was unchanged (Jonec & Finch, 1975) .
in

Km

The

The increase

was suggested to be due to a decreased "native"

affinity for dopamine.

Alternatively, an endogenous com-

petitive inhibitor may be present in the aged mice, whose
inhibition can be overcome at high dopamine concentrations.
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MEMBRANE COMPOSITION AND FLUIDITY IN
NEUROTRANSMITTER SYSTEMS
The effect of increasing membrane fluidity on
epinephrine- and adenosine-stimulated adenylate cyclase has
been studied using cis-vaccenic acid as a fluidizing agent
and fluorescence polarization with DPH to determine the
membrane microviscosity (Rimon et al., 1978).

There are

two types of adenylate cyclase-receptor coupling mechanisms, a mobile receptor, and a receptor that is permanently
coupled to adenylate cyclase.

If the receptor is mobile,

requiring lateral diffusion to activate adenylate cyclase,
it would be expected that the activation would be increased
with increasing fluidity (decreasing the resistance to
lateral diffusion) .

This was observed in the epinephrine-

stimulated adenylate cyclase system, known to act through a
mobile receptor.

The adenosine receptor, on the other

hand, is believed to be permanently coupled to adenylate
cyclase.

As would be expected in this type of system, the

activation of adenosine-sensitive adenylate cyclase was
independent of membrane fluidity (Rimon et al., 1978).
The influence of membrane fluidity on the binding
of serotonin (Heron et al., 1980a,b) and opiates (Heron et
al., l980a; Heron et al., 1981) to their receptors was
studied.

Crude synaptosomes were incubated with lecithin

or linoleic acid, to increase fluidity, or with cholesteryl
hemi-succinate or stearic acid, to decrease fluidity.

De-

creasing membrane fluidity (increasing viscosity) produced
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a 5-fold increase in [ 3 H]-serotonin binding and a 2-fold
increase in [ 3 H]-enkephalin and ( 3 H]-naloxone binding.
As the viscosity was increased further, binding was rapidly
lost, possibly due to increased degradation or "shedding"
of receptors into the medium (Heron et al., 1980a,b; Heron
et al., 1981).

Fluidization of the membrane produced a de-

crease in the binding of all three ligands.

The authors

suggest that their observations with more viscous membranes
have implications in aging and chronic drug treatment.
Dopamine receptors have been studied as a function
of membrane fluidity using spiperone as a ligand (Henry &
Roth, 1986).

The concentrations of spiperone used, 0.25 to

10 nM, would characterize primarily the

o2 receptor.

Crude striatal membranes from mature (3-6 months of age)
and aged rats (24-25 months of age) were incubated with up
to 10% (v/v) ethanol for 15 minutes to fluidize the membranes.

Incubation with cholesterol hemisuccinate for 2

hours produced an increase in membrane viscosity.

Spip-

erone binding to membranes from both mature and aged animals showed an increase in the Kd for spiperone as the
membrane was made more rigid.

However, there was no dif-

ference between the response in mature and aged animals
that were subjected to identical treatments.

The Bmax

for spiperone binding was lower in the aged animals.

But

the Bmax for membranes from both mature and aged animals
was decreased as the membrane viscosity was artifically
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increased.

Fluidizing the membrane with ethanol had no

effect on either the

Ka

or Bmax for spiperone binding

to membranes from mature or aged animals (Henry & Roth,
1986).
In the above studies (Heron et al., 1980a,b; Heron
et al., 1981; Henry & Roth, 1986), incubation times of up
to 2 hours at room temperature were utilized to alter the
membrane fluidity.

In our hands, the incubation of mem-

branes for more than 45 minutes in buffer produced changes
in the binding kinetics of the o1 receptor.

Therefore, a

method which utilizes shorter incubation times may be the
method of choice for studies of this type.
One such method was described by North and
Fleischer (1983a,b) who altered the Chol/PL of synaptosomes
and SPM using liposomes made of cholesterol and/or PC, and
a non-specific lipid transfer protein (ns-LTP) from beef
liver (Crain & Zilversmit, 1980).

The altered membranes

were studied to determine the effect of changes in membrane
fluidity on sodium-dependent GABA uptake and GABA binding.
This method has advantages over other, non-protein-mediated
methods because a large change in Chol/PL can be achieved
using short incubation times (30-60 minutes).

Using the

ns-LTP, the Chol/PL of SPM was varied from 0.21 to 1.19,
from the normal value of 0.52.

The Chol/PL of synaptosomes

was varied from 0.16 to 0.81, from the normal value of 0.38
(North & Fleischer, 1983a,b). It should be noted that the
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Chol/PL of synaptosomes is lower than that of SPM.

This

difference is due to the presence of mitochondria containing little cholesterol within the synaptosomes.

The in-

crease in Chol/PL, and accompanying decrease in membrane
fluidity as determined by DPH fluorescence polarization,
produced no changes in either GABA uptake or binding (North

& Fleischer, 1983b).

Decreasing the Chol/PL of synapto-

somes to 40% of normal produced a 70-100% loss of GABA
uptake and a 50% decrease in the Bmax for GABA binding.
NONSPECIFIC LIPID TRANSFER PROTEIN
Lipid transfer proteins (LTP) are present in the
cytosol of many tissues and vary in their specificity toward the various lipid classes.

In beef liver, two types

of LTPs have been identified (Zilversmit, 1983), a PCspecific transfer protein with a molecular weight of 28,000
and an isoelectric point, P 1 , of 5.8, and two ns-LTPs,
CMI and CMII, both with molecular weights of 14,500 and
P 1 s of 9.55 and 9.75, respectively (Crain & Zilversmit,
1980).

The ns-LTPs accelerate the transfer of cholesterol

and many phospholipid depending on their relative concentration in the donor and acceptor membranes.

These two

proteins differ in composition by two amino acids, CMI
containing no arginine or histidine, and CMII containing
one each of these amino acids.

CMI and CMII will transfer

cholesterol in preference to PC, even at Chol/PL as low as
0.2 (donor membrane)

(Crain & Zilversmit, 1980).

Since
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these proteins do not transfer cholesterol esters or
triglycerides, these lipids can be used as nontransferrable
markers.

The in vivo function of ns-LTPs is not known,

but, based on their amino acid composition, it appears that
CMII may be identical to a Sterol Carrier Protein (SCP 2 ),
which shuttles intermediates in cholesterol biosynthesis
between the inner and outer mitochondrial membranes (Noland
et al., 1980; Crain, 1982).
Ns-LTP has been used to alter the Chol/PL of SPM
and synaptosomal membranes as previously described (North &
Fleischer, 1983a,b).

This method has advantages over pre-

viously used methods which required long incubation times.
Because a wide range of Chol/PL can be obtained using short
incubation times, the integrity and biological activity of
SPM and synaptosomes can be preserved.

CHAPTER III
MATERIALS AND METHODS
Purification of Lipid Transfer Protein from Beef Liver
Nonspecific Lipid Transfer Protein (ns-LTP) was
partially purified from beef liver by a modification of the
methods of Crain and Zilversmit (1980), and North and
Fleischer (1983b)
at 4°c.

(Figure 5).

All steps were carried out

Fresh beef liver was obtained from Aurora Pack-

ing Copmany, North Aurora, Illinois.

A 35% (w/v) homogen-

ate was prepared in a solution containing 0.25 M sucrose, 1
mM EDTA, 50 rnM Tris HCl, 0.02% (w/v) sodium azide, pH 7.4
(SET buffer), and centrifuged at 13,000 x g (9,000 rpm in
GS3 rotor, Sorvall RC-SB centrifuge) for 30 minutes.

The

supernatant was decanted and the pH adjusted to 5.1 with 3
N HCl.

After mixing for 30 minutes, the solution was cen-

trifuged at 13,000 x g (9,000 rpm) for 20 minutes.

The

clear supernatant (5.1 Supernatant) was decanted and the pH
returned to 7.4 with 3 N NaOH.

Aliquots of 900 ml were

stored at -20°c for up to 6 months.
Two 900 ml aliquots of 5.1 Supernatant were
thawed.

over 1 hour, ammonium sulfate was added to 40%

saturation (243 g/liter).

After an additional hour of mix-

ing, the solution was centrifuged at 13,000 x g (9,000 rpm)
for 30 minutes.

The supernatant was decanted and addition38

FIGURE 5
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PREPARATION OF LIPID TRANSFER PROTEIN
Fresh

eef liver
35% (w/v) homogenate in SET
buffer pH 7.4
cfg 9,000 rpm, 30 min

pellet
(discard)

supernatant
adjust pH to 5.1, mix 30 min
cfg 9,000 rpm, 20 min

pellet
(discard)

supernatant
(5.1 Supernatant)
adjust pH to 7.4
(may be frozen)
add ammonium sulfate to
40% saturation
mix 1 hour
cfg 9,000 rpm, 30 min

pellet
(discard)

supernatant
add ammonium sulfate to
90% saturation
mix 1 hour
cfg 9,000 rpm, 30 min

supernatant
(discard)

pellet
suspend in 25 mM Na 2 HP0 4
10 mM 2-mercaptoetnanol
0.02% NaN 3 , pH 8.1

dialyze against 5 mM Na 2 HP0 4 , 5mM 2-mercaptoethanol, 0.02% NaN 3 , pH 8.1
load onto Sepharex CM-C25 column
wash column with 2 volumes dialysis buffer

I

elute from column with 2 volumes 25 mM Na 2 HP0 4 ,
45 mMaCl, 5 mM 2-mercaptoethanol, 0.02% NaN 3 , pH 8.1
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al ammonium sulfate was added over 1 hour to 90% saturation (375 g/liter).

After 1 hour of mixing, the solution

was centrifuged at 13,000 x g (9,000 rpm) for 30 minutes.
The supernatant was discarded, and the pellet was suspended
in a solution containing 25 rnM sodium phosphate, 10 rnM 2mercaptoethanol, 0.02% (w/v) sodium azide, pH 8.1.

The

suspension was extensively dialyzed against a solution
containing 5 rnM sodium phosphate, 5 rnM 2-mercaptoethanol,
0.02% (w/v) sodium azide, pH 8.1 (dialysis buffer), using
Spectra/Per 1 (Spectrum Medical Industries, Inc., Los
Angeles) dialysis tubing with a molecular weight cutoff of
6000-8000 daltons.
The dialysate was applied, at a flow rate of 1
ml/min, to a 5 x 60 cm Sephadex CM-C25 (Pharmacia, Inc.,
Uppsala, Sweden) ion exchange column, which had been preequilibrated with dialysis buffer.

The column was washed

with 2 column volumes of dialysis buffer, and eluted, at a
flow rate of 2 ml/min, with 2 column volumes of a solution
containing 25 rnM sodium phosphate, 45 rnM NaCl, 5 rnM 2-mercaptoethanol, 0.02% (w/v) sodium azide, pH 8.1 (elution
buffer) .

LTP was eluted following a large peak of yellow

material.

Transfer activity was stable for up to 1 month

when stored at 4°C in elution buffer.

Prior to use in

lipid transfer experiments, the eluate was concentrated 5to 10- fold by ultrafiltration through an Amicon stirred
ultrafiltration cell, equipped with a Diaflo YM5 membrane,
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with a molecular weight cutoff of 5000 daltons (Amicon
Corp., Danvers, MA).
SOS-PAGE
To qualitatively determine the purity of the
transfer protein preparations, aliquots of fractions from
the different purification steps were separated by sodium
dodecyl sulfate (SOS) polyacrylamide gel electrophoresis
(PAGE) .

Samples were prepared in a solubilizing solution

and boiled for 2 minutes at

ioo 0 c.

The solubilizing

solution was prepared from 1 ml of 10% (w/v)

sos,

150 mg

dithiothreitol, and 800 mg sucrose in 10 ml of deionized
water.

Bromothymol blue was added and the samples were

centrifuged before application to the gel.
Slab Gel Preparation.

Because the expected molec-

ular weight of the transfer protein was approximately 14K,
gels of 12.5% (w/v) acrylamide were prepared to assure a
good separation in the low molecular weight region.

Gels

of 3 mm thickness were prepared with 41.7 ml Solution A
(below), 12.5 ml Solution B, 1 ml of Solution

c,

44.65 ml

deionized water, 0.15 ml TEMEO (diluted 1:10 with deionized
water), and 100 mg ammonium persulfate.

After pouring, the

gels were overlayed with isobutanol and allowed to polymerize.

After polymerization, the gels were rinsed with de-

ionized water and blotted.

Spacer gels of 3% (w/v) acryl-

amide were prepared with l ml Solution A, 1.25 ml Solution
D, O.l ml Solution

c,

8.15 ml deionized water, 0.05 ml
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TEMED (diluted 1:10 with deionized water) and 10 mg ammonium persulfate, and poured within a few mm of the top of
the comb used to form the sample wells.

Solution A con-

tained 30% (w/v) acrylamide and 0.8% (w/v) Bis.
contained 36.6% (w/v) Tris base, pH 8.9.
tained 10% (w/v) SDS.

Solution B

Solution

c con-

Solution D contained 5.89% (w/v)

Tris base, pH 6.7.
Samples were applied and overlayed with running
buffer.

The running buffer contained 0.02% (w/v) SDS, 1.4%

(w/v) glycine, 0.3% (w/v) Tris pH 8.4.

Low molecular

weight standards (Bio-Rad), including lysozyme (14.4K),
soybean trypsin inhibitor (21.SK), carbonic anhydrase
(31K), ovalbumin (45K), bovine serum albumin (66.2K), and
phosphorylase B (92.SK), were run with samples in each
gel.

Current was applied at 10 amps per gel until the

samples reached the stacking gel.

Thereafter, the current

was maintained at 20 amps per gel.

Gels were run until the

tracking dye reached the end of the gel.

Gels were fixed

and stained in a solution containing 0.1% (w/v) Coomassie
Blue, 50% (v/v) methanol, and 10% (v/v) acetic acid, followed by destaining in a solution containing 7.5% (v/v)
acetic acid and 7.5% (v/v) methanol.
PREPARATION OF MITOCHONDRIA FOR CHOLESTEROL TRANSFER ASSAY
Mitochondria were prepared using an adaptation of
the method of Cotman and Matthews (1971).

A 10% (w/v) hom-

ogenate of beef heart was prepared in 0.32 M sucrose, 5 mM
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Tris base, pH 7.0 (sucrose buffer) using a Tekmar tissumizer (Tekmar, Cincinnati, OH).

The homogenate was centri-

fuged at 1,100 x g (3,000 rpm in an SS34 rotor) for 5
minutes.

The supernatant was decanted into clean centri-

fuge tubes and centrifuged at 17,000 x g (13,700 rpm) for
10 minutes.

The pellet was suspended in 15 ml of sucrose

buffer and layered onto 15 ml of 38% (w/v) sucrose, followed by centrifugation at 106,000 x g (24,250 rpm in SW-28
rotor) for 2 hours.

The pellet was resuspended in sucrose

buffer and stored at -8o 0 c.

Prior to use in the choles-

terol transfer assay, mitochondria were heated to 8o 0 c
for 20 minutes to inactivate endogenous lipases.

Heat-

treated mitochondria were subsequently washed with 50 mM
Tris HCl, pH 7.4.
PREPARATION OF LIPOSOMES
Liposomes that would be used in an assay of cholesterol transfer activity were prepared with 1 mg egg PC
per ml, 1 mole of cholesterol per mole of PC, with 0.25 µCi
each of [ 3 H]-triolein and [ 14 c]-cholesterol per ml of
liposomes added as nontransferrable and transferrable markers, respectively (North & Fleischer, 1983b).

Liposomes,

for depletion of cholesterol from synaptosomes or SPM, were
prepared using 10 mg of egg phosphatidylcholine (PC) per
ml.

Those to be used to increase the Chol/PL of synapto-

somes and SPM were prepared with 5 mg PC per ml with 1.7
moles of cholesterol per mole of PC (4.4 mg cholesterol per

44
ml).

[ 14 c]-Tripalmitin (0.25 µCi/ml) was included in all

liposomes as a nontransferrable marker (North & Fleischer,
1983b).

To prepare liposomes, the lipids were mixed in

chloroform and dried under nitrogen to a thin film which
coated the walls of an acid-washed tube.

The lipid layer

was dispersed in 50 mM Tris HCl, pH 7.4 (for the liposomes
to be used for the cholesterol transfer assay) or 0.32 M
sucrose, 5 mM Tris base, pH 7.0 (for the liposomes to be
used for cholesterol loading and depletion) by extensive
mixing using a vortex mixer, followed by sonication until
the lipid mixture was transleucent, using a Cole Palmer
Ultrasonic Homogenizer 4710 (Cole Palmer Instrument Co.,
Chicago, IL), equipped with a 1/2 inch tipped horn, at 80%
duty cycle.

After sonication, the liposomes were centri-

fuged at 27,000 x g (15,000 rpm, SS34 rotor) for 60 minutes
at 25°c to remove titanium fragments from the sonicator
tip and undispersed lipid.

Liposomes were generally used

within 3 hours of preparation.
CHARACTERIZATION OF LIPOSOMES
In order to correct for the sticking of liposomes
to the synaptosomes and SPM in the calculation of the Chol/
PL, it is necessary to establish that the phospholipid,
cholesterol, and nontransferrable marker are uniformly distributed throughout the population of each type of liposome
used.

To accomplish this, the liposomes were chromato-

graphed on a Sepharose 4B-CL column (Wong et al., 1982),
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with 50 mM Tris HCl, pH 7.4 as the running buffer.

Before

applying the liposomes to be separated, the column was saturated with unlabelled liposomes, to occupy the hydrophobic
binding sites, and washed extensively.

Fractions of 1 ml

were collected and assayed for phosphorus and cholesterol.
The radioactivity in each fraction was determined by liquid
scintillation counting.
ASSAY OF CHOLESTEROL TRANSFER ACTIVITY
Cholesterol transfer activity was assayed by
incubating purified transfer protein (up to 100 µl) with
800 ul of liposomes and 100 ul of heat-treated mitochondria
at 32°c for varying times.

Blanks (without transfer

protein) were included for each time point.

The reaction

was terminated by vacuum filtration through Whatman GF/C
filters, which had been preincubated with unlabelled
liposomes, followed by 3 washes with 5 ml of 50 mM Tris
HCl, pH 7.4 (North & Fleischer, 1983b).

Filters were

placed in 10 ml of Ecoscint and the radioactivity determined in a Beckman LS-7500 liquid scintillation counter
with data reduction.
The purpose of the assay was to demonstrate a
unidirectional transfer of cholesterol from a donor liposome into mitochondria.

The mitochondrial membrane is a

good acceptor because it contains very little cholesterol.
The liposomes used in the assay contained [ 14 c)-Cholesterol and [ 3 H]-Triolein as transferrable and nontrans-
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ferrable markers, respectively.

After the incubation, the

mitochondria will have a 14 c; 3 H that is greater than
the 14 c; 3 H of the liposomes, it a net transfer has
taken plase.
1 4 c due to
sticking
net 14 c

=

The net transfer was calculated as follows:

= (3H

in sample)x( 14 c; 3 H in liposomes)

14 c in sample - 14 c due to sticking

nmol chol = net 14 c x nmole ihol in liposomes
1 C in liposomes
transferred
PREPARATION ON SYNAPTOSOMES AND SYNAPTIC PLASMA MEMBRANES
Synaptosomes and synaptic plasma membranes (SPM)
were prepared from whole rat brain by the method of Cotman
and Matthews (1971)
at

(Figure 6).

All steps were carried out

4°c.
Male Sprague-Dawley rats (Holtzman, Madison, WI),

40 +/- 5 days old were housed 3 to a cage with a 12 hour
light dark cycle.

Animals were sacrificed between 7 a.m.

and 8 a.m. by decapitation.

The brains were removed and

placed in ice cold 0.32 M sucrose, 5 mM Tris base, pH 7.0
(sucrose buffer).

A 10% (w/v) homogenate was prepared

using a glass homogenizer with a teflon pestle.

The tissue

was homogenized at 1000 rpm, with 4 up and down strokes.
The homogenate was centrifuged at 1100 x g (3,000 rpm in
SS34 rotor, Sorvall RC-5B centrifuge) for 5 minutes.

The

supernatant was decanted into clean centrifuge tubes and
pelleted at 17,000 x g (13,700 rpm) for 10 minutes.

The

pellet was resuspended in 15 ml of sucrose buff er using a

FIGURE 6
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RAT SYNAPTOSOMES AND SYNAPTIC PLASMA MEMBRANES

Fresh rat whole brain
10% (w/v) homogenate in

I

~,--------~--1-

P1

--------11

S1

( dis.-c_a_r_d_)

I

S2

(discard)

sucrose buff er
cfg 3,000 rpm, 5 min

cfg 13,700 rpm, 10 min

P2

suspend in 15 ml sucrose
buff er (hand-held
homogenizer)
cfg 11,000 rpm, 20 min
. 3

(discard)
layer onto Ficoll gradient
(13.0%/7.5%)

cfg 22,000 rpm (SW 28 rotor)
45 min
Synaptosomes found at 7.5%/13.0% Ficoll interface. Remove
·
interface and dilute w/
4 vol sucrose buff er
cfg 24,250 rpm, 30 min
pellet (synaptosomes)
osmotically shock in 6 mM
Tris, pH 8.1, 90 min
cfg 20,300 rpm, 15 min
pellet
suspend in 5 ml sucrose
buff er
layer onto sucrose gradj.ent
(38%/35%/32.5%/25%/10%)

cfg 24,250 rpm, 90 min
SPM found at 25%/32.5% sucrose interface.
Remove interface and dilute w/4 vol
sucrose buff er
cfg 24,250 rpm, 30 min
pellet (SPM) - suspend in sucrose buffer - store -00°c
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round bottom, hand-held glass homogenizer, prior to
centrifugation at 11,000 x g (11,000 rpm} for 20 minutes.
The pellet was suspended in 5 ml of sucrose buffer and
layered onto a discontinuous Ficoll-sucrose gradient
consisting of 13 ml of 13.0% (w/v) Ficoll 400 in sucrose
buffer and 13 ml of 7.5% (w/v) Ficoll 400 in sucrose
buffer.

Following centrifugation at 63,581 x g (22,000 rpm

in SW-28 rotor, Beckman L5-65 ultra-centrifuge) for 45 minutes, the synaptosomal material, found at the 7.5%/13.0%
Ficoll interface, was removed, diluted with 4 volumes of
sucrose buffer, prior to centrifugation at 106,000 x g
(24,250 rpm) for 30 minutes. The pellet contained synaptosomes which were used directly for cholesterol transfer
and dopamine uptake assays.
To prepare SPM for membrane fluidity studies, the
synaptosomal pellet was suspended in a small volume of sucrose buffer, osmotically shocked with 6 volumes of 6 mM
Tris base, pH 8.1 for 90 minutes, and centrifuged at 54,500
x g (20,300 rpm) for 15 minutes.

The resulting pellet was

resuspended in 5 ml of sucrose buff er and layered onto a
discontinuous sucrose gradient which consisted of the following concentrations of sucrose solutions with 5 mM Tris
base, pH 7. O, in ascending order:
35.0% (w/v)
ml).

(5 ml), 32.5% (w/v)

38. 0% (w/v)

( 5 ml) ,

(5 ml), and 25.0% (w/v)

(10

The gradient was centrifuged at 106,000 x g (24,250

rpm) for 90 minutes.

SPM, found at the 32.5%/25.0% inter-
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face, were removed, diluted with 4 volumes of sucrose buffer, and pelleted at 106,000 x g (24,250 rpm) for 30 minutes.

The pellet was suspended in a small volume of su-

crose buffer and stored at

-so 0 c.

Bovine brain was obtained as a generous gift from
Aurora Packing Company, North Aurora, Illinois.

Fresh

brains were kept ice-cold in 50 mM Tris HCl, pH 7.4, during
transportation.

The caudate was removed (Yoshikawa, 1968),

and homogenized in sucrose buff er as described for rat
brain.

Because the bovine myelin and synaptosomal frac-

tions were found to have a lower density than those from
rat brain, it was necessary to make two modifications of
the Cotman and Matthews (1971) method.

1) In the prepara-

tion of synaptosomes, the Ficoll-sucrose gradient consisted
of 13 ml of 14.0% (w/v) Ficoll and 13 ml of 6.0% (w/v) Ficoll.

2)

In the isolation of SPM from synaptosomes, the

25% (w/v) sucrose solution from the sucrose gradient was

replaced by 20.0% {w/v) sucrose (Figure 7).

Bovine synap-

tosomes were used directly for cholesterol transfer and

o1

binding and adenylate cyclase assays.

at

-so 0 c.

SPM were stored

MARKER ENZYME ASSAYS
The relative purity of SPM and synaptosomes prepared from rat whole brain and bovine caudate was assessed
by determining the activities of enzymatic markers.
Mg 2 +-dependent, ouabain-sensitive (Na+-K+)-ATPase {EC

FIGURE 7
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BOVINE SYNAPTOSOMES AND SYNAPTIC PLASMA MEMBRANES
Fresh bovine caudate

..--~~~~~~~j :::
P1
(discard)

rl

.-~~~~~~~~~-1

(w/v) homogenate in
sucrose buff er
3,000 rpm, 5 min

cfg 13,700 rpm, 10 min

S2
(discard)
suspend in 15 ml sucrose
buff er (hand-held
homogenizer)
cfg 11,000 rpm, 20 min
S3
(discard)
layer onto Ficoll gradient
(14.0%/6.0%)
cfg 22,000 rpm (SW 28 rotor)
45 min
Synaptosomes found at 6.0%/14.0% Ficoll interface. Remove
interface and dilute w/
4 vol sucrose buff er
cfg 24,240 rpm, 30 min
pellet (synaptosomes)
osmotically shock in 6 mM
Tris, pH 8.1, 90 min
cfg 20,300 rpm, 15 min
pellet
suspend in 5 ml sucrose
buff er
layer onto sucrose gradient
(38%/35%/32.5%/20%/10%)
cfg 24,250 rpm, 90 min
SPM found at 20%/32.5% sucrose interface
Remove interface and dilute w/4 vol
sucrose buff er

.

cfg 24,250 rpm, 30 min
pellet (SPM) - suspend in sucrose buffer - store -8o 0 c
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3.6.1.4)

(Sweadner, 1978) is found enriched in plasma mem-

branes.

Acid phosphatase (EC 3.1.3.2)

(Linhardt & Walter,

1963), cytochrome c oxidase (EC 1.9.3.1)

(Duncan & Mackler,

1966), and 2',3'-cyclic nucleotide 3'-phosphohydrolase,
CNPase (EC 3.1.4.16)

(Kurihara & Tsukada, 1967) are

enzymatic markers for lysosomal, inner mitochondrial, and
myelin membranes respectively.
Na+-K+ ATPase.

Na+K+-dependent, Mg 2 +-

stimulated, ouabain-sensitive ATPase is a marker for plasma
membranes.

Enzyme activity was assayed by a modification

of the method of Abdel-Latif et al.

(1970).

All samples

were preincubated for 2 minutes at room temperature in
0.02% (w/v) SDS.

Rat whole brain and bovine caudate hom-

ogenates (90-100 ug protein), synaptosomes (50-80 ug protein), or SPM (30-50 ug protein) were incubated in 450 µl
of reaction mixture for 10 minutes at 37°c before initiating the reaction with 50 µl of ATP (18 mg ATP per ml final concentration 3 mM ATP).
tained:

The final assay buffer con-

150 mM NaCl, 20 mM KCl, 3 mM MgC1 2 , 40 mM Tris

base, and 3 mM ATP, pH 7.4.

Ouabain sensitivity was deter-

mined in the presence of 10 mM ouabain.

After 10 minutes,

the reaction was terminated by the addition of 150 µl of
ice cold 50% (w/v) trichloroacetic acid, and placing the
tubes in an ice bath.

After centrifugation at low speed, a

500 µl aliquot of the supernatant was removed for quantitation of the inorganic phosphate released in the reaction,
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using this laboratory's modification of the Fiske Subbarow
phosphorus assay (Fiske & Subbarow, 1925)

(assay described

on page 63).
CNPase.

CNPase, a marker for myelin, was assayed

by the method of Kurihara and Tsukada (1967).

Tissue sam-

ples were prepared in 1% (v/v) Triton X-100 to give a concentration of 0.25 µg protein/µl.

The reaction tubes, con-

taining 50 µl of 0.03 M 2',3'-cAMP, 50 ul of a solution
containing 0.2 M Na 2 HP0 4 and 0.1 M citrate pH 6.2, and
80 µl deionized water, were preincubated for 5 minutes at
37°C.

The reaction was initiated by the addition of 20

µl of tissue in Triton x-100.

Tubes without tissue were

also included as substrate blanks.

After 20 minutes, the

reaction was terminated by the addition of 20 µl of glacial
acetic acid and the tubes were placed on ice.

After cen-

trifugation at low speed, a 20 µl aliquot of the supernatant was removed for separation on Whatman chromatography
paper, using isopropanol:ammonia:water, 7:1:2 (v/v/v)
(Banik and Davison, 1969) as the solvent system.

The paper

was dried in air and the nucleotide spots were visualized
under ultraviolet light and marked.

Spots corresponding to

substrate, product, and paper blank were cut into small
pieces and placed in test tubes.

Four ml of 0.01 N HCl was

added to each tube prior to shaking for at least 2 hours at
room temperature.

The paper was removed by low speed cen-

trifugation and the optical density (O.D.) of the superna-
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tant was determined at 260 nm.

Calculations were as

follows:
S1

=

Asubstrate standard - Apaper blank

P1

=

Aproduct - Apaper blank

x = s 1 /l.5 =
y

=

z =

3(P 1 /X)

Absorbance/µmole/assay

=

µmole/20 µl of assay/hour

Y/mg protein in 20 µl

Acid Phosphatase.

=

µmole/hour/mg protein

Acid phosphatase, a marker for

lysosomes, was assayed by the method of Linhardt and Walter
(1963).

The assay buffer (500 ul) containing 50 mM cit-

rate, 5.5 mM p-nitrophenyl phosphate pH 4.8, was preincubated for 5 minutes at 37°c.

The reaction was initiated

by the addition of 50 µl of homogenate (100-500 µg protein), synaptosome or SPM (50 µg protein), and allowed to
proceed for 30 minutes at 37°c.

Blanks, without tissue,

and standards containing 2.5-10 x 10- 5 moles of p-nitrophenol were included.

The reaction was terminated by the

addition of 2 ml of 0.1 N NaOH.

The

o.o.

of blanks, stand-

ards, and samples was determined at 405 nm.

Calculations

were as follows:
(A 405 ) (2.81)/(.5) (mg protein)

=

mmole acid

phosphatase units (mmole/hr/mg protein)
Cyctochrome c Oxidase.

Cyctochrome c oxidase, a

marker for mitochondria, was assayed by the method of
Duncan and Mackler (1966).

The assay measures the rate of

the decrease in absorbance at 550 nm due to the cytochrome
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c oxidase-catalyzed conversion of f errocytochrome c
(Fe 2+) to ferricytochrome c (Fe 3+).

Ferrocytochrome c

was prepared by the addition of sodium dithionite to ferricytochrome c.

Excess dithionite was removed by aeration.

To the assay buffer, containing 0.2 ml of 0.2 M phosphate
buffer, pH 7.5, 0.1 ml of 1% (w/v) ferrocytochrome c, and
0.7 ml deionized water, tissue was added to give an absor-

bance change that was linear for 2-5 minutes.

The enzyme

activity was calculated from the slope of the linear decrease in absorbance as a function of time as follows:
(change in A550 /min)/(total absorbance change/µmole
cytochrome c) (mg protein) = µmole/min/mg protein.
CHOLESTEROL TRANSFER
Synaptosomes for the o1 binding and adenylate
cyclase assays and SPM for fluidity studies (1 mg of protein in 50 µl of 0.32 M sucrose) were preincubated for 10
minutes at 32°c with 200 ul of concentrated transfer protein in elution buffer, 80 µl of 1.8 M sucrose, and 170 µl
of deionized water to give a final sucrose concentration of
0.32 M.

The extent of cholesterol transfer was controlled

by the amount of transfer protein added.

The reaction was

initiated by the addition of 500 µl of liposomes and
allowed to continue for 30 minutes (synaptosomes) or 60
minutes (SPM) with gentle shaking.

The shorter incubation

time was used for the synaptosomes because the viability of
the synaptosomes was compromised, and the kinetics of
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dopamine binding was altered with longer incubation times.
The transfer was terminated by centrifugation through a
layer of 0.5 M sucrose at 106,000 x g (24,250 rpm in SW-28
rotor) for 40 minutes (North and Fleischer, 1983b).
Several modifications were made in the cholesterol
transfer procedure for the synaptosomes used for the dopamine uptake studies (North & Fleischer, 1983b).

1) So-

dium azide, which inhibits uptake processes, was removed
prior to use in the cholesterol transfer from the transfer
protein solution by dialysis against elution buffer without
sodium azide.

2) In addition, 15% (v/v) Krebs-Henseleit

buffer (see below) was included in the incubation medium to
preserve synaptosome viability without inhibiting the
transfer activity.

3) The reaction was terminated by

centrifugation at 63,581 x g (22,000 rpm in SW-28 rotor)
through 0.5 M sucrose containing 40% (v/v) Krebs-Henseleit
buffer.
After cholesterol transfer, the surface of each
pellet was rinsed to remove any sedimented lipid.
pellet was then suspended in the assay buffer.

The

Binding,

uptake, and adenylate cyclase assays were performed immediately after the cholesterol transfer.
FLUORESCENCE POLARIZATION DETERMINATION OF MEMBRANE
FLUIDITY
The fluidity of SPM from rat whole brain and bovine caudate was determined using fluorescence polarization
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techniques.

The surface and the hydrophobic core of the

membrane were probed using l-anilinonaphthalene-8-sulfonic
acid (ANS) and l,6-diphenyl-1,3,5-hexatriene (DPH), respectively.

The SPM fraction was used rather than the more

crude synaptosomal fraction because the hydrophobic fluorescent probes will partition into all cellular membranes.
A semi-crude fraction contains mitochondria, which are low
in cholesterol content and thereby very fluid, and myelin,
which is high in cholesterol content and, hence, very rigid.

Fluorescence polarization analysis of such mixed

membrane fractions could confound the interpretation of the
data.
For the DPH studies, SPM (50 ug of SPM protein)
were incubated with 1 µM DPH in phosphate buffered saline
(PBS), pH 7.4 (136.9 mM NaCl, 2.68 mM KCl, 8.1 mM
Na 2 HP0 4 , 1.47 mM KH 2 Po 4 ) at 37°c for 30 minutes to allow
the probe to equilibrate into the membrane.

SPM for the

ANS study were incubated at room temperature for 15 minutes
with 200 µMANS in PBS containing 10 mM Mgso 4 .

The di-

valent magnesium cation was used to neutralize surface
negative charges and to allow the ANS to interact more
efficiently with the membrane, and hence to enhance the
fluorescence signal.
The fluorescence of the SPM was determined in a
Perkin Elmer MPF-44B Fluorescence Spectrophotometer,
equipped with rotating polarizing filters.

For the DPH
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studies, an excitation wavelength of 360 (slit width 3 nm)
and emission wavelength of 430 nm (slit width 20 nm) were
used (Shinitzky & Barenholz, 197S).

For the ANS studies,

an excitation wavelength of 395 (slit width 5 nm) and emission wavelength of 490 nm (slit width 20 nm) were used
(Slavik, 19S2).

The fluorescence of the prepared samples

was determined at different orientations of the polarizing
filters.
DOPAMINE UPTAKE ASSAY
The uptake of dopamine into control and lipidmodified synaptosomes was assayed by a modification of the
method of Deskin et al.

(19Sl).

After lipid transfer,

synaptosomes were gently suspended in modified KrebsHenselei t buffer (llS mM NaCl, 26 mM Na 2 HP0 4 , 6 mM
NaH 2 Po 4 , 4.7 mM KCl, 1.S mM CaC1 2 , 1.2 mM MgS0 4 , 1.3 mM
EDTA, 5.6 mM D-glucose, 2 µM ascorbic acid, 10 µM
pargyline, pH 7.4) for assay.

Triplicate 100 µl aliquots

of prepared synaptosomes, containing 200-300 µg of
synaptosomal protein, were added to 900 µl of Krebs buffer,
containing 10-15 nM of [ 3 HJ-dopamine and 0-5,000 nM of
unlabelled dopamine (Figure Sa).

Nonspecific uptake was

determined in the presence of 10 µM nomifensine (Figure Sb)
(Hunt et al., 1974).

All samples were incubated for 5

minutes at 37°c with gentle shaking.

The reaction was

terminated by transferring the tubes to ice and adding 2 ml
of ice cold Krebs buffer.

All samples were vacuum filtered

Figure 8

a) Structure of Dopamine
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b) Structure of Nomifensine

Cl
HO

c) Structure of SCH23390

d) Structure of Butaclamol
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through Whatman GF/F filters and washed twice with 3 ml of
Krebs buffer.

Radioactivity associated with the filters

was determined as described previously.
parameters

~

The kinetic

and Vmax were calculated for each assay

by Hanes plot analysis.

The Hanes plot is a linear

transformation of the data which plots s/v (the substrate
concentration/the observed rate) on the Y-axis and s
substrate concentration) on the X-axis.
the

~

(the

From this plot,

is the negative X- intercept, and the Vmax is

l/slope.
DOPAMINE CD 1 ) BINDING ASSAY
The dopamine o 1 binding sites in control and
lipid-modified membranes were assayed using the method of
Hess et al.

(1986) with SCH23390 (Figure Sc) as a ligand.

After cholesterol transfer, synaptosomes were suspended in
50 mM Tris pH 7.4 containing 5 mM Mgso 4 .

Membranes were

incubated at 37°c for 15 minutes, followed by centrifugation at 20,000 x g for 20 minutes, to remove endogenous
dopamine.

The pellets were suspended in a solution con-

taining 50 mM Tris, 5 mM Mgso 4 , 0.5 mM EDTA, and 0.02%
(w/v) ascorbic acid, pH 7.4 (assay buffer).

Duplicate 100

µl aliquots of synaptosomes, containing 300-500 pg of
synaptosomal protein were added to 2.9 ml of assay buffer
containing 0.2-0.5 nM of ( 3 H]-SCH23390, and 0-5.1 nM of
unlabelled SCH23390.

Samples were incubated at 37°c for

30 minutes with gentle shaking.

Nonspecific binding was
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determined in the presence of 1 µM (+)-butaclamol (Figure
8d)

(Seeman et al., 1985).

The reaction was terminated by

vacuum filtration through Whatman GF/C filters, followed by
three washes with 5 ml of 50 mM Tris, pH 7.4.

The radio-

activity associated with the filters was determined as
described previously.

The kinetic parameters,

Ka

and

Bmax' were calculated for each assay by Scatchard
analysis.

The Scatchard plot is a linear transformation of

the experimental data in which the ratio of the concentrations of bound ligand and free ligand is plotted on the
Y-axis and the concentration of bound ligand is plotted on
the X- axis.

From the Scatchard plot, the Bmax is the

X-intercept, and the

Ka

is -1/slope.

DOPAMINE-SENSITIVE ADENYLATE CYCLASE ASSAY
Basal and dopamine-sensitive adenlyate cyclase
activity was assayed using control and lipid-modified bovine caudate synaptosomal membranes by a modification of
the methods of Enjalbert et al.
(1980), and Waldman et al.
dopamine

(1978), Makman et al.

(1985).

Synaptosomes from the

o 1 binding assays were used directly for the

adenylate cyclase assays.
were preincubated at

3o 0 c

Synaptosomes (50 µg of protein)
in a solution containing 80 mM

Tris-maleate, 2 mM Mgso 4 , 2 mM isobutylmethylxanthine,
0.2 mM EGTA, 20 mM creatine phosphate, 0.2 mg/ml creatine
kinase, and 50 µM GTP, pH 7.4, in the presence or absence
of 100 µM dopamine.

The reaction was initiated by the
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addition of 0.5 mM ATP and allowed to proceed for 5 minutes.

The reaction was terminated by the addition of 50 mM

sodium acetate pH 4.0 and immersion in a boiling water bath
for 3 minutes.

Precipitated protein was removed by centri-

fugation at 23,000 x g (15,000 rpm in SE12 rotor) for 15
minutes.

The supernatants were stored at

-ao 0 c

until

cyclic AMP radioimmunoassays were performed.
CYCLIC AMP RADIOIMMUNOASSAY
The cAMP radioimmunoassay was a modification of
the method of Steiner (1972a,b).

Before the RIA was run,

all samples and standards were acetylated to more closely
duplicate the antigen used to generate the antibody.

This

acetylation step greatly increases the sensitivity of the
assay.

To acetylate samples, 20 µl of triethylamine and 10

µl of acetic anhydride were added to 500 ul of standards
and samples.

Duplicate 100 µl aliquots of standards

(containing O to 500 fmole of cAMP) and samples were
transferred to 12 x 75 mm tubes, and 100 µl of [ 125 IJcAMP, in 50 mM sodium acetate, pH 6.2, was added.

To start

the assay, 100 µl of anti-cAMP antibody (primary antiserum
to cAMP) in acetate buffer was added, and the tubes were
incubated in the refrigerator for 12 hours.

The assay was

stopped by the addition of 50 µl of 1% gamma globulin in
acetate buffer and 2 ml of ice-cold 95% isopropanol.

The

tubes were centrifuged, in a Jouan GR4.11 centrifuge, at
1,623 x g (2800 rpm) for 30 minutes at 4°c and the super-
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natant was decanted.

The radioactivity associated with the

pellets was determined in a gamma counter.
PROTEIN DETERMINATION
Protein was assayed following the method of Lowry
et al.

(1951).

Human serum albumin (HSA), prepared at a

concentration of 1 mg/ml in deionized water, was used as a
protein standard.
of protein.

The standard curve consisted of 0-50 µg

Standards and samples were incubated in 0.1 ml

of 1 N NaOH for 30 minutes at room temperature to solubilize membrane-bound proteins.

To each tube was added 1 ml

of a solution freshly prepared with 10 ml of 2% (w/v) sodium carbonate, 0.1 ml of 1% (w/v) cupric sulfate, and 0.1
ml of 2% (w/v) K+-Na+ tartrate.

After 10 minutes, 0.1

ml of 1 N Folin phenol reagent was added.

After 30 min-

utes, the O.D. of standards and samples was determined at
700 nm.
CHOLESTEROL ASSAY
Cholesterol was assayed using a diagnostic kit
(Sigma Kit 351).

The assay, which quantitates both cho-

lesterol esters and cholesterol, combines cholesterol
esterase, cholesterol oxidase, and peroxidase in a colorimetric reaction.

Cholesterol esters are hydrolyzed to free

cholesterol and fatty acids by cholesterol esterase.

The

cholesterol is then oxidized to cholest-4-en-3-one and
hydrogen peroxide by cholesterol oxidase.

The hydrogen
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peroxide reacts with 4-amino-antipyrine and phenol in the
presence of peroxidase to form a quinoneimine dye which has
an absorbance maximum at 500 nm.

The reagent contains a

detergent (sodium chelate) to free membrane bound cholesterol and gives a linear response up to 60 ug of cholesterol.

Blanks, aqueous cholesterol standards, and tissue

samples (containing up to 60 µg of cholesterol) were incubated with 1 ml of reagent at 37°c for 10 minutes.

The

o.D. of samples and standards was determined at 500 nm
against the blank.

Because turbidity in the samples can

lead to overestimation of the cholesterol content, the O.D.
of each sample and standard was determined after the addition of 2 drops of 0.5 M ascorbate, which will decolorize
the reaction mixture.

The net absorbance was used to cal-

culate the cholesterol content.
PHOSPHORUS ASSAY
Phospholipid and inorganic phosphate was determined by a modification of the method of Fiske and
Subbarrow (1925).

Before determining the phosphorus

concentration of SPM and synaptosomes, the tissue samples
were extracted three times with chloroform:methanol (2:1)
(Folch et al., 1957).

The chloroform layers were combined

and dried under nitrogen.

To each residue was then added

0.1 ml of 70% perchloric acid.

Each tube was digested at

17o 0 c until no yellow color remained.

ml of deionized water was added.

After cooling, 1

A standard solution of
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o.04 mg/ml of KH 2 Po 4 was prepared.

To standards of o

to 40 µg of phosphorus in 1 ml of deionized water, 0.1 ml
of 70% perchloric acid was added.

To each standard and

sample, 0.25 ml of 2.5% ammonium molybdate, 0.1 ml of
reducer, and deionized water, up to a total volume of 2.5
ml, were added.

After 10 minutes at room temperature, the

o.D. of the standards and samples was determined at 625
nm.

The reducer was prepared by dissolving 3 g of

Na 2 so 3 , 60 g of NaHso 3 ,and 1 g of 1-amino-2-naphthalene-4-sulfonic acid in 500 ml of deionized water.
CALCULATION OF CHOL/PL
In order to determine an accurate Chol/PL for the
lipid-modified SPM and synaptosomes, it was necessary to
correct the cholesterol and phospholipid phosphorus concentrations for the sticking of liposomes.

This was made

possible by the inclusion of [ 14 c]-tripalmitin in the
liposomes as a nontransferrable marker.

The radioactivity

in the liposomes and tissue samples was determined by liquid scintillation counting.

The corrected Chol/PL was cal-

culated as follows:
nmole chol due
to sticking
nmole PL due
to sticking
net chol
net PL

=

=

= ( 14 c

= c14 c

in sample) x (nmole chol/ 14 c)
in liposomes

in sample) x (nmol PL/ 14 c)
in liposomes

(total chol - chol due to sticking)/mg protein

(total PL - PL due to sticking)/mg protein

corrected Chol/PL

= net

chol/net PL
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DATA ANALYSIS
Mean values reported for the marker enzyme activities, adenylate cyclase activities, and Chol/PL of control
membranes represent the mean +/- the standard deviation of
several samples, where n

=

the number of determinations.

student's 't' test for significance was used when comparing
the marker enzyme activities of synaptosomes and SPM to
homogenates.

P values of <0.05 were considered to repre-

sent significant differences.
Data from the dopamine uptake studies was analyzed
by Hanes plot analysis of triplicate determinations.

Km

The

and Vmax values for each assay were calculated from

the X-intercept and the slope, respectively.

Only assays

with as least 5 data points and a correlation coefficient
of 0.9 or better for the linear fit of the Hanes plot were
included.
Data from the SCH23390 binding studies was analyzed by Scatchard analysis of duplicate determinations.
The

Ka

and Bmax were calculated from the slope and

X-intercept, respectively.

The criteria for inclusion of

assays was identical to that used for the dopamine uptake
studies.
Linear analysis of standard curves, Hanes and
Scatchard plots was by the method of least squares.

Unless

otherwise noted, the lines describing the relationship between the Chol/PL and the various parameters studied were
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estimated from the data to show a general trend, and were
not calculated from theoretical equations relating Chol/PL
to the experimental parameters.
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CHEMICALS
chemical

Source

sucrose

J.T. Baker, Phillipsburg, NJ

EDTA

Sigma, St. Louis, MO

Trizma HCl

Sigma

Trizma OH

Sigma

Sodium azide

Sigma

Ammonium sulfate

Sigma

2-Mercaptoethanol

Sigma

Ficoll-400

Pharmacia, Upsala, Sweden

Egg phosphatidyl choline

Sigma

Sodium phosphate, monobasic

Sigma

Sodium phosphate, dibasic

Sigma

Sodium chloride

Sigma

Cholesterol

Sigma

[ 14 c]-Cholesterol

Amersham, Arlington Heights,
IL

[ 3H]-Triolein

ICN Radiochemicals, Irvine, CA

[ 14 c]-Tripalmitin

Amersham

Potassium chloride

Mallinckrodt, Paris KY

Calcium chloride

Baker

Magnesium sulfate

Mallinckrodt

D-Glucose

Mallinckrodt

Ascorbic Acid

Sigma

Pargyline

Sigma

Dopamine

Sigma
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CHEMICALS (cont.)
Chemical

Source

[ 3 HJ-Dopamine

New England Nuclear, Boston MA

Nomifensine

Hoechst-Roussel, Somerville,
NJ

Ecoscint

National Diagnostics,
Manville, NJ

SCH23390

Research Biochemicals, Inc.,
Wayland, MA
New England Nuclear

(+)-Butaclamol

Research Biochemicals, Inc.

Tris-maleate

Sigma

Isobutylmethylxanthine

Sigma

EGTA

Sigma

Creatine phosphate

Sigma

Creatine kinase

Sigma

GTP

Sigma

ATP

Sigma

ANS

Molecular Probes, Inc.,
Junction City, OR

DPH

Molecular Probes, Inc.

Potassium phosphate, monobasic

Baker

sos

Sigma

Magnesium chloride

Sigma

Trichloroacetic acid

Sigma

Triton X-100

Aldrich Chemical, Milwaukee,
WI

2 1 ,3 1 -cAMP

Sigma
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CHEMICALS (cont.)
Chemical

Source

sodium citrate

Baker

rsopropanol

Mallinckrodt

Ammonia

Mallinckrodt

p-Nitrophenyl phosphate

Sigma

Ferricytochrome c

Sigma

Sodium dithionite

Fisher Scientific, Fair Lawn,
NY

Acrylamide

Sigma

bis-Acrylamide

Eastman Kodak, Rochester, NY

Glycine

Sigma

Bromothymol blue

Sigma

Ammonium persulfate

Sigma

Isobutanol

Eastman Kodak

TEMED

Sigma

Methanol

Baker

Acetic Acid

Mallinckrodt

Coomassie blue

Sigma

anti-cAMP antibody

Research Products International, Mt. Prospect, IL
Sigma
Meloy Laboratories, Springfield, VA

Gamma-globulin

Sigma

Triethylamine

Sigma

Acetic anhydride

Sigma
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CHEMICALS (cont.)
chemicals

Source

HSA

Sigma

K+-Na+ tartrate

Mallinckrodt

CHAPTER IV
RESULTS
NONSPECIFIC LIPID TRANSFER PROTEIN
Purification of Lipid Transfer Protein
The lipid transfer protein was eluted from the
Sephadex CM-C25 ion exchange column in a single peak which
immediately followed a large peak containing yellow material (Figure 9).

It was necessary to extensively wash the

column with the dialysis buffer prior to elution in order
to achieve a good separation of the LTP peak.
cation of LTP is represented in Table I.

The purifi-

After the ammo-

nium sulfate precipitation, there was an increase in the
apparent yield of transfer activity.

This may have been

due to the removal of possible endogenous inhibitors in the
5.1 Supernatant fraction.

After the ion exchange chromato-

graphy, the LTP had been purified 217-fold over the 5.1
Supernatant.

The yield of transfer activity was 53%.

Figure 10 depicts the separation of proteins in the LTP
fraction, the 5.1 Supernatant, and the ammonium sulfate
fractions by SOS-PAGE.

As shown in Figure 10, the

purification of LTP yielded an enrichment of transfer
activity and a reduction of the contaminating proteins.
From the Rf of the molecular weight standards and the LTP
71
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figure 9. The Elution of LTP from Sephadex CM-C25.

After ammonium sulfate precipitation and dialysis, the
aialysate was applied to a Sephadex CM-C25 ion exhange
column and washed extensively with dialysis buffer.

The

transfer protein was eluted with 2 volumes of a solution
containing 25 mM sodium phosphate, 45 mM NaCl, 5 mM 2rnercaptoethanol, and 0.02% (w/v) sodium azide.

The O.D. of

individual fractions was determined at 280 nm to follow the
elution.

The LTP peak was identified by its cholesterol

transfer activity.
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TABLE I
PURIFICATION OF LIPID TRANSFER PROTEIN

VOLUME
(ml)

PROTEIN
(mg/ml)

TOTAL
PROTEIN
(mg)

5.1
SUPERNATANT

1390

26.27

36515

0.3

10955

100

1

AMMONIUM
SULFATE

750

27.77

20828

0.89

18599

170

3

CM-C25

380

0.23

88.54

65.24

5776

53

FRACTION

SPECIFIC
TOTAL
ACTIVITY
ACTIVITY
(nmol chol
transferred/
mg protein)

% YIELD

PURIFICATION

217

Lipid Transfer Protein was partially purified from beef liver as described in the
Materials and Methods. Aliquots of the 5.1 Supernatant, the ammonium sulfate fraction
and the LTP fraction obtained after ion exchange chromatography on Sephadex CM-C25,
were assayed for cholesterol transfer activity as described.
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figure 10. SOS-PAGE of Fractions from the Purification of
LTP.

The separating gel contained 12.5% (w/v) acrylamide and the
stacking gel contained 3% (w/v) acrylamide.

The arrows

indicate the LTP band in each experimental lane.
Lane 1: 5.1 Supernatant (100 µg protein)
Lane 2: Ammonium Sulfate fraction (100 µg protein)
Lane 3: LTP fraction (10 µg protein)
Lane 4: Low molecular weight standards
Phosphorylase B, 92.5 K
Bovine Serum Albumin, 66.2 K
Ovalbumin, 45 K
Carbonic Anhydrase, 31 K
Soybean Trypsin Inhibitor, 21.5 K
Lysozyme, 14.4 K
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band, the apparent molecular weight of LTP was calculated
as 14,300 daltons (Figure 11).

It was not necessary to

continue the purification to homogeneity because the most
important contaminating protein, a PC-specific transfer
protein with a Pr of 5.8 (Zilversmit, 1983), would be
expected to be removed during the ion exchange chromatography.

The molecular weight of this PC-specific transfer

protein is 28,000 daltons (Zilversmit, 1983).

In the SDS-

PAGE of the LTP fraction, no bands appeared in this molecular weight region (Figure 10).
ASSAY OF CHOLESTEROL TRANSFER ACTIVITY
The purpose of the assay was to demonstrate a
unidirectional transfer of cholesterol from a donor liposome into mitochondria.

The mitochondrial membrane is a

good acceptor because it contains very little cholesterol.
The amount of cholesterol in the mitochondrial membrane
preparation was below the limits of detection for the
cholesterol assay.

The liposomes used in the assay con-

tained PC and cholesterol (1:1, mole:mole) as well as
[ 3 H]-triolein and [ 14 c]-cholesterol.

After the incuba-

tion, the mitochondria will have a 14 c/ 3 H that is
greater than the 14 c; 3 H of the liposomes, if a net
transfer of cholesterol has taken place.

An assumption

that must be made is that the 14 c, 3 H, and cholesterol
in these liposomes are uniformly distributed throughout the
population of liposomes.

In order to show this, the
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figure 11. Sodium Dodecyl Sulfate Polyacrylamide Gel
Electrophoresis of the LTP Sample.

From the Rf of the LTP band after SDS-PAGE on a 12.5%
acrylamide gel, the apparent molecular weight of LTP was
determined to be 14,300 daltons.
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liposomes were chromatographed on Sepharose 4B-CL.

Each

fraction was assayed for phospholipid phosphorus and
cholesterol, and the radioactivity was determined by liquid
scintillation counting.

The distrubution of lipid and

radioactivity in the liposomes for the transfer assay is
shown in Figure 12.

One population of liposomes is found.

The phosphorus (Pi), cholesterol, 3 H, and 14 c coeluted,
indicating that the liposomes were uniform in composition.
The results of a typical transfer assay using beef
heart mitochondria is shown in Figure 13.

The nonspecific

transfer increased linearly over the time assayed and
accounted for approximately 20% of the total cholesterol
transferred.

The specific transfer was nearly linear for

up to 25 minutes.
RELATIVE PURITY OF SYNAPTOSOMES AND SPM
RAT WHOLE BRAIN MEMBRANES
Rat whole brain synaptosomes and SPM were prepared.

The relative purity of these fractions, as compared

to homogenates, is shown in Table II.

Each determination

is the average of tissue from four preparations.

Na+-

K+-ATPase, found primarily in plasma membranes, was enriched in both the synaptosomal and SPM fractions, 1.7- and
4.7-fold, respectively.

The relative specific activities

of acid phosphatase, cyctochrome c oxidase, and CNPase demonstrate a significant reduction in the contamination of
the synaptosomal and SPM preparations by lysosomal, mito-
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figure 12. Sepharose 4B-CL Chromatography of Liposomes
used for Cholesterol Transfer Assay.

Liposomes were prepared containing 1 mg PC/ml and 1 mole of
cholesterol per mole of PC.

[ 14 c]-Cholesterol was

included as a transferrable marker.

[ 3 H]-Triolein was

included as a nontransferrable marker.

One ml of liposomes

was loaded onto the column (1 x 15 cm) and was eluted with
20 ml of 50 mM Tris HCl, pH 7.4.

One ml fractions were

collected and assayed for cholesterol and phospholipid
phosphorus.

The radioactivity in each fraction was

determined by liquid scintillation counting.
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Figure 13. Cholesterol Transfer Activity of Purified LTP.

cholesterol transfer activity was assayed by incubating
heat-treated mitochondria with LTP and [ 14 c)- and
[3HJ-labelled liposomes for varying time periods at
3 2°c.

The reaction was terminated by filtration through

GF/C filters, followed by 3 washes with 5 ml of 50 mM Tris
HCl, pH 7.4.

Nonspecific transfer was determined in the

absence of LTP.

The radioactivity associated with the

filters was determined by liquid scintillation counting.
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TABLE III
ACTIVITY OF ENZYME MARKERS IN BOVINE BRAIN SYNAPTOSOMES AND SYNAPTIC PLASMA MEMBRANES
HOMOGENATE

SYNAPTOSOME

SPM

Na+K+ATPase
µg Pi released/hr/
mg protein
Relative specific activity

2.89 +/- 0.79

4.91 +/- 0.49*

12.73 +/- 4.73**

1

1. 70

4.40

Acid Phosphatase
nmole substrate hydrolyzed/
hr/mg protein
Relative specific activity

13.49 +/- 1. 85

12.65 +/- 1.95

1

0.94

cytochrome c Oxidase
µmole substrate hydrolyzed/
min/mg protein
Relative specific activity

0.555 +/- 0.017

CNPase
µmole product formed/hr/
mg protein
Relative specific activity

1665.3 +/- 120.6

1

1

0.260 +/- 0.080*
0.47
1049.5 +/- 110.9**
0.63

10.34 +/- 3.67
0.77
0.100 +/- 0.030**
0.18
818.8 +/- 193.4**
0.49

Na+K+ATPase (plasma membranes), acid phosphatase (lysosomes), cytochrome c oxidase
(mitochondria), and CNPase (myelin) assays were performed on samples from 4 individual
membrane preparations. The relative specific activity is used to compare the specific
activities of synaptosomes and SPM to that of the homogenates. Values of greater than
one represent enrichment of the enzyme activity.
* Values are statistically different from the homogenates at P<.05.
** Values are statistically different from the homogenates at P<.01.

(X)

U1
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chondrial, and myelin membranes, respectively.
BOVINE CAUDATE MEMBRANES
Bovine caudate synaptosomes and SPM were initially
prepared following the method of Cotman and Matthews (1971)
(Figure 6).

The myelin fraction was not well separated in

the Ficoll gradient or the sucrose gradient.

Because of

the high cholesterol content and microviscosity of the myelin membrane, it is desirable to minimize the contamination of the synaptosomal and SPM preparations with myelin.
Thus, the gradients used to isolate synaptosomes and SPM
were modified as described in the Materials and Methods.
This allowed the isolation of relatively pure fractions.
The relative purity of synaptosomes and SPM prepared using the modified method is compared to membrane
homogenates (Table III).

Each determination is the average

of four separate preparations.

Na+-K+-ATPase was

enriched in both the synaptosomal and SPM fractions, 1.7and 4.4-fold, respectively.

The relative specific activ-

ities of cytochrome c oxidase and CNPase demonstrate a
significant reduction in the contamination of synaptosomal
and SPM preparations by mitochondrial and myelin membranes,
respectively.

However, the CNPase activity in each of the

bovine caudate fractions was approximately 6-fold higher
than that found in rat whole brain (Table II).

The

contamination by lysosomal membranes, as identified by the
activity of acid phosphatase, was not significantly

TABLE II
ACTIVITY OF ENZYME MARKERS IN RAT BRAIN SYNAPTOSOMES AND SYNAPTIC PLASMA MEMBRANES
HOMOGENATE

SYNAPTOSOME

SPM

Na+K+ATPase
µg Pi released/hr/
mg protein
Relative specific activity

4.64 +/- 1.15

7.97 +/- 1. 92*

21. 87 +/- 3.14**

l

1. 72

4.74

Acid Phosphatase
nmole substrate hydrolyzed/
hr/mg protein
Relative specific activity

18.18 +/- 2.12

15.23 +/- 2.10*

8.95 +/- 0.76+·w

0.84

0.49

Cytochrome c oxidase
µmole substrate hydrolyzed/
min/mg protein
Relative specific activity

0.675 +/- 0.064

CNPase
,umole product formed/hr/
mg protein
Relative specific activity

291.0 +/- 37.8

l

l

l

1.195 +/- 0.040*

0.192 +/- 0.031**

0.29

0.18

135.2 +/- 32.2*

128.0 +/- 17.3**

0.46

0.44

Na+K+ATPase (plasma membranes), acid phosphatase (lysosomes), cytochrome c oxidase
(mitochondria), and CNPase (myelin) assays were performed on samples from 4 individual
membrane preparations. The relative specific activity is used to compare the specific
activities of synaptosomes and SPM to that of the homogenates. Values of greater than
one represent enrichment of the enzyme activity.
* Values are statistically different from the homogenates at P<.05.
** Values are statistically different from the homogenates at P<.01.
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different from the homogenates.
CHOLESTEROL TRANSFER
RAT WHOLE BRAIN MEMBRANES
Accurate calculation of the Chol/PL in all experimental membranes required the correction of cholesterol and
phosphorus content for the sticking of liposomes.

The in-

clusion of [ 14 c]-tripalmitin in the liposomes made this
correction possible.

However, in order for this correction

to be accurate, the cholesterol, PL, and 14 c label must
be uniformly distributed throughout the liposome population.

The analysis of the fractions from Sepharose 4B-CL

chromatography of PC and PC-Chol liposomes is shown in
Figures 14 and 15, respectively.

Two populations of PC

liposomes were found, due to the high concentration of PC
{10 mg/ml).

The radioactivity eluted with the phosphorus.

One population of PC-Chol liposomes was found.

Phosphorus,

cholesterol, and radioactivity were coeluted from the
column.

These results suggest that, in both the PC and

PC-Chol liposomes, the radioactivity was associated with
the liposomes and the correction for liposome sticking was
accurate.
The analysis of rat whole brain SPM from a typical
lipid transfer experiment is shown in Table IV.

The change

in Chol/PL was paralleled by a change in cholesterol/protein.

Although the PL/protein was slightly increased, this

change, which was up to 10.55% of control, was small when
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Figure 14. Sepharose 4B-CL Chromatography of PC Liposomes
used for Cholesterol Transfer.

pc liposomes, prepared in sucrose buffer, contained 10 ml
pc/ml.

One ml of liposomes was loaded onto the column {1 x

15 cm) and eluted with 20 ml of sucrose buffer.

One ml

fractions were collected and assayed for phospholipid
phosphorus.

The radioactivity in each fraction was

determined by liquid scintillation counting.

Figure 15. Sepharose 4B-CL Chromatography of PC-Chol Liposomes used for Cholesterol Transfer

PC-chol liposomes, containing 5 ml PC/ml and 1.7 mole of
cholesterol per mole of PC, were chromatographed as
described in Figure 14.

The fractions were assayed for

phospholipid phosphorus and cholesterol.

The radioactivity

in each fraction was determined by liquid scintillation
counting.
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TABLE IV
CHOLESTEROL DEPLETION AND LOADING OF RAT BRAIN SPM
ANALYSIS OF LIPID-MODIFIED SPM
CHOL
PROTEIN
nmole
mg

__N,_ _

PROTEIN
nmole
mg

CHOL
PL
mole
mole

PC

378

985

.384

PC

410

967

PC

465

TYPE OF
LIPOSOME
USED

% CHANGE

CHANGE IN
PL
nmole
mg protein

-137

-26.60

+18

.424

-105

-20.39

0

1056

.440

-50

-9.71

515

967

.533

0

PC-CHOL

633

975

.649

+118

+22.91

+8

+0.82

PC-CHOL

744

1032

.720

+229

+44.47

+65

+6.72

PC-CHOL

938

1069

.878

+423

+82.14

+102

+10.55

NONE

*

CHANGE IN
CHOL
nmole
mg protein

0

+89
0

% CHANGE

+1.86
0

+9.20
0

The results presented are from a typical cholesterol transfer experiment using SPM.
Similar results were obtained using synaptosomes. SPM were incubated with liposomes
and varying amounts of transfer protein, from 0.1 to 0.4 mg per ml of incubation
mixture. PC liposomes were used for cholesterol depletion. PC-CHOL liposomes were
used for cholesterol loading. All membranes were assayed for protein, cholesterol, and
phospholipid phosphorus. Also, the sticking of liposomes to the membranes was
corrected for by the inclusion of [ 14 c)-tripalmitin in the liposomes. All values
presented are after the correction for the sticking of liposomes. The changes in
cholesterol and phospholipid are as compared to the control (*), which was incubated
without liposornes.
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compared to the change in cholesterol/protein, which is up
to 82.14%.

As shown in Table IV, the alteration of the

cholesterol content of SPM using LTP was effective with
little change in the phospholipid composition of the membranes.
BOVINE CAUDATE MEMBRANES
The analysis of bovine caudate SPM from a typical
lipid transfer experiment is shown in Table

v.

The change

in Chol/PL was paralleled by the change in Chol/protein.
The PL/protein was slightly altered.
FLUORESCENCE POLARIZATION
RAT WHOLE BRAIN MEMBRANES
The hydrophobic core of the membrane was probed
with DPH.

When incorporated into SPM, the magnitude of the

DPH fluorescence signal was proportional to the amount of
SPM lipid present.

The polarization (P) value was inde-

pendent of the lipid and protein concentration.

The most

reproducible P values were obtained at a membrane protein
concentration of 50 pg per 3 ml.

Fluorescence polarization

and anisotropy (r) values decreased with increasing temperature (Figure 16) .

A decrease in P or r indicates a de-

crease in the relative microviscosity (Figure 17).

Arrhen-

ius plots of the DPH anisotropy (Figure 16) of cholesteroldepleted and cholesterol-loaded membranes, having Chol/PL
of 0.366 and 0.878, respectively, showed no discontinuities

TABLE V
CHOLESTEROL DEPLETION AND LOADING OF BOVINE BRAIN SPM
ANALYSIS OF LIPID-MODIFIED SPM
TYPE OF
LIPOSOME
USED

CHOL
PROTEIN
nmole
mg

PL
PROTEIN
nmole
mg

CHOL
PL
mole
mole

CHANGE IN
CHOL
nmole
mg protein

% CHANGE

CHANGE IN
PL
nmole
mg protein

% CHANGE

PC

386

1031

.375

-166

-30.07

+23

+2.28

PC

430

999

.430

-122

-22.10

-9

-0.89

PC

495

1020

.485

-57

-10.33

+12

+l.19

552

1008

.547

0

PC-CHOL

625

1009

.619

+73

+13.22

+l

+0.10

PC-CHOL

713

1023

.697

+161

+29.17

+15

+l. 49

PC-CHOL

844

1012

.834

+292

+52.90

+4

+0.40

NONE

*

0

0

0

The results presented are from a typical cholesterol transfer experiment using SPM.
Similar results were obtained using synaptosomes. SPM were incubated with liposomes
and varying amounts of transfer protein, from 0.1 to 0.4 mg per ml of incubation
mixture. PC liposomes were used for cholesterol depletion.
PC-CHOL liposomes were
used for cholesterol loading. All membranes were assayed for protein, cholesterol, and
phospholipid phosphorus. Also, the ~ticking of liposomes to the membranes was
corrected for by the inclusion of ( 1 C]-tripalmitin in the liposomes. All values
presented are after the correction for the sticking of liposomes. The changes in
cholesterol and phospholipid are as compared to the control {*),which was incubated
\0
w
without liposomes.
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figure 16. Arrhenius Plots of DPH Anisotropy in Rat
Brain SPM

DPH anisotropy (r) was calculated from polarization (P)
values measured at 4°c, 15°c, 25°c, 37°c, and 5o 0 c.
Representative plots for cholesterol-depleted (Chol/PL
o.366,

o ),

=

control (Chol/PL= 0.553,x ), and cholesterol-

loaded (Chol/PL= 0.878, v) membranes are shown.
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figure 17. The Relative Microviscosity of the Hydrophobic
Core of Rat Brain SPM as a Function of Chol/PL.

The relative microviscosity was calculated from DPH r
values measured at 4 °c
31°c (

* ),

( o ) , 15°c ( x ) , 2s 0 c ( v

and so 0 c ( o).

is 0.543 +/- 0.014 (n

=

),

The Chol/PL of control SPM

4).

be considered physiological.

Chol/PL of 0.35 to 0.706 could
The lines were generated to

fit a theoretical sigmoidal curve that approximated the
experimental data.
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suggestive of a sharp phase transition over the temperature
range of 4°C to 5o 0 c.

In contrast, the Arrhenius plot

of the DPH anisotropy of the control membrane was curvilinear with limiting slopes at the low and high temperatures similar to those of the high and low cholesterolcontaining membranes respectively.
The relationship between the relative microviscosity of the hydrophobic core of rat whole brain SPM
and Chol/PL is shown in Figure 17.

The DPH data appeared

to fit a sigmoidal relationship, with an inflection point
at a Chol/PL of 0.58.

In the range of Chol/PL of 0.5 to

0.65, there was an increase in the relative microviscosity
at each temperature studied.

At Chol/PL above and below

this range, the relative microviscosity was relatively
independent of Chol/PL.

At 37°c, a 10% increase in

Chol/PL produced a 75% increase in the relative microviscosity.

A further increase in Chol/PL produced a smaller

effect.

A similar decrease in Chol/PL produced a change in

the relative microviscosity of 30%.

The greatest change in

the relative microviscosity occurred in the range of
Chol/PL of 0.5 to 0.6.

The Chol/PL of control rat whole

brain SPM was 0.543 +/- 0.014 (n

=

4).

The membrane surface was probed with ANS.

Because

ANS binds to proteins as well as to lipids in the membrane,
it was important to establish the assay conditions which
would optimize the signal from the lipid-bound ANS.

At

99
lower concentrations of ANS, up to 100 µM, the wavelength
of the emission maximum was 480 nm.

This wavelength is

characteristic of ANS bound to proteins (Slavik, 1982).
Above 200 µM ANS, the wavelength of the emission maximum
was 495 nm.

At this concentration, the fluorescence signal

would be expected to be due to ANS bound primarily to
lipids (Slavik, 1982).

This was further verified by the

wavelength of the emission maximum of ANS bound to liposomes, 495 nm.

A membrane protein concentration of 100 µg

per 3 ml was found to produce the most reproducible P
values.
As seen with the DPH probe, the anisotropy (r)
values decreased with increasing temperature (Figure 18).
This indicates an increase in relative microviscosity
(Figure 19).

Arrhenius plots of ANS anisotropy (Figure 18)

of control, cholesterol-depleted, and cholesterol-loaded
membranes, having Chol/PL of 0.384. 0.553, and 0.782,
respectively, showed a response to temperature similar to
that observed with the control membranes using DPH over the
temperature range of

4°c

to

37°c.

Also, the plots for

membranes with Chol/PL of 0.553 and 0.782 are nearly superimposable, suggesting that increasing the Chol/PL had
little effect on the relative microviscosity at the membrane surface (Figure 19).

A small temperature range was

studied because as the temperature was increased, the magnitude of the fluorescence signal decreased sharply.

ioo
Figure 18. Arrhenius Plots of ANS Anisotropy in Rat
Brain SPM.

ANS anisotropy (r) was calculated from P values measured at
4oc,

2s 0 c, and 37°c.

depleted (Chol/PL

=

Representative plots for cholesterolO. 3 84, O ) , control (Chol/PL

o. 553, x ) , and cholesterol-loaded (Chol/PL
membranes are shown.

=

= O. 782,

v)
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figure 19. The Relative Microviscosity of the Surface of
Rat Brain SPM as a Function of Chol/PL.

The relative microviscosity was calculated from ANS r
values measured at 4°C ( o), 25°c ( x ) , and 37°c
(v ).
4).

The Chol/PL of control SPM is O. 543 +/-

o. 014 (n =

Chol/PL of 0.35 to 0.706 could be considered

physiological.

The lines were generated to fit a

theoretical sigmoidal curve that approximated the
experimental data.
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The relationship between the relative microviscosi ty at the membrane surface and Chol/PL is shown in
Figure 19.

The ANS data also appeared to fit a sigmoidal

relationship.
PL of 0.50.

However, the inflection point was at a Chol/
In the range of Chol/PL of 0.45 to 0.6, there

was an increase in relative microviscosity at each temperature studied.

At Chol/PL above and below this range, the

relative microviscosity was independent of Chol/PL.

At

37°c, the overall change was less dramatic than was seen
with DPH.

The greatest change occurred in the range of

Chol/PL of 0.5 to 0.6.
0.543 +/- 0.014 (n

=

The Chol/PL of control SPM was

4).

Comparing the hydrophobic core (Figure 17) and the
membrane surface (Figure 19), at each Chol/PL, the relative
microviscosity of the hydrophobic core of the membrane was
greater than that at the surface.

However, above a Chol/PL

of 0.6, the difference was much greater.

The core of the

membrane was much more rigid than the surface at high Chol/
PL.

As seen in Figures 19 and 17, respectively, the mem-

brane surface was more sensitive to decreases in Chol/PL,
while the hydrophobic core was more sensitive to increases
in Chol/PL.
BOVINE CAUDATE MEMBRANES
Bovine caudate SPM were assayed in the fluorescence studies as described for rat brain SPM.

The hydro-

phobic core of the membrane was probed with DPH.

Polariza-
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tion (P) and anisotropy (r) values decreased with increasing temperature (Figure 20), indicating a decrease in
microviscosity (Figure 21).

Arrhenius plots of the DPH

anisotropy (Figure 20) of control, cholesterol-depleted,
and cholesterol-loaded membranes, having Chol/PL of 0.547,
0.345, and 0.881, respectively, were curvilinear, with the

greatest curvature evident at the lowest Chol/PL,
suggesting that any change in state of the interior of the
bovine caudate SPM would be most evident at lower Chol/PL.
The relationship between the relative microviscosi ty of the hydrophobic core of bovine caudate SPM and
Chol/PL is shown in Figure 21.

The bovine SPM did not

exhibit the same sigmoidal relationship as did the SPM from
rat brain.

This may have been due to the higher amounts of

cholesterol-rich myelin that were present in the preparations (Table III).

As the Chol/PL was decreased from 0.6,

there was a decrease in microviscosity at each temperature
studied.

The greatest decrease occurred at lower

temperatures (4°c and 15°c) and smallest at 5o 0 c.
Furthermore, at the lower temperatures, the midpoint of the
transition in microviscosity occured at Chol/PL below the
physiological, as expected from the Arrhenius plot.

At

37°c, increasing the Chol/PL produced only a gradual

increase in microviscosity with a maximal change over the
range studied of 170%.

Furthermore, no dramatic changes in

the relative microviscosity are seen in the region of the
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Figure 20. Arrhenius Plots of DPH Anisotropy in Bovine
Caudate SPM.

DPH anisotropy (r) was calculated from P values measured at

4°c, 15°c, 25°c, 37°c, and 5o 0 c.

Representative

plots for cholesterol-depleted (Chol/PL= 0.345,o ),
control (Chol/PL= 0.547, x) and cholesterol-loaded
(Chol/PL = 0.881,

~)

membranes are shown.
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figure 21. The Relative Microviscosity of the Hydrophobic
Core of Bovine Caudate SPM as a Function of
Chol/PL.

The relative microviscosity was calculated from DPH r

values measured at 4°c ( o), is 0 c ( x), 2s 0 c ( v),
37oc (

* ),

and so 0 c ( <> ) •

was 0.542 +/- 0.026 (n

=

The Chol/PL of control SPM
4).

Chol/PL of 0.30 to 0.705

could be considered physiological.
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physiological Chol/PL, which had a value of 0.542 +/- 0.026
(n

=

4).

The membrane surface was probed with ANS.

Bovine

caudate SPM were assayed under conditions identical to
those used to study the rat whole brain SPM.

As with DPH,

the ANS anisotropy (r) values decreased with increasing
temperature (Figure 22), corresponding to a decrease in
relative microviscosity (Figure 23).

Arrhenius plots of

ANS anisotropy (Figure 22) of control, cholesterol-depleted, and cholesterol-loaded SPM, having Chol/PL of
0.504, 0.351, and 0.834, respectively, were similar to
those observed for the rat membranes.
The relationship between the relative microviscosi ty at the membrane surface and Chol/PL is shown in
Figure 23.

As with DPH, there was a decrease in the rela-

tive microviscosity as the Chol/PL decreased from 0.6.

At

Chol/PL above this point, no further change in microviscosity was detected.

At 37°c, increasing the Chol/PL

produced only a small increase in the relative microviscosity, up to 20% over the control.

However, decreasing

the Chol/PL to 0.46 produced a 52% decrease in the relative
microviscosity.

Again, the midpoint of the change in the

surface microviscosity occurred at a Chol/PL below the
physiological value of 0.542 +/- 0.026 (n = 4).
Comparing the hydrophobic core (Figure 21) and the
surface (Figure 23) of bovine caudate SPM, at each Chol/PL,
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figure 22. Arrhenius Plots of ANS Anisotropy in Bovine
Caudate SPM.

ANS anisotropy (r) was calculated from P values measured at
4oc,

2s 0 c,

and

37°c.

Representative plots for cholesterol-

depleted (Chol/PL= 0.351,D ), control (Chol/PL=
o.504,x ), and cholesterol-loaded (Chol/PL= 0.834, v)

membranes are shown.
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figure 23. The Relative Microviscosity of the Surface of
Bovine Caudate SPM as a Function of Chol/PL.

The relative microviscosity was calculated from ANS r
values measured at 4°C ( o), 25°c ( x), and 37°c
(v).
4)·

The Chol/PL of control SPM was 0.542 +/- 0.026 (n
Chol/PL of 0.30 to 0.705 could be considered

physiological.
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the relative microviscosity of the hydrophobic core of the
membrane was greater than that at the membrane surface.

In

contrast to rat whole brain SPM (Figures 17 and 19), the
surface and hydrophobic core of bovine caudate SPM were affected by the presence of cholesterol in a similar way.
Both regions of the membrane were more sensitive to decreases in Chol/PL than to increases in the Chol/PL at
values near that of the control (Figures 21 and 23).
DOPAMINE UPTAKE STUDIES USING RAT WHOLE BRAIN MEMBRANES
The uptake of [ 3 HJ-dopamine into control, cholesterol-depleted, and cholesterol-loaded rat whole brain
synaptosomes was studied.

Each experimental set of five

samples included synaptosomes which had been incubated with
PC liposomes or PC-Chol liposomes, using two concentrations of LTP for each type of liposome.

A control was in-

cluded in each set, which was incubated under standard conditions, except that sucrose buffer was substituted for the
liposomes.
A typical assay for control synaptosomes is shown
in Figure 24.

For control samples, a concentration range

of 10-1000 nM dopamine was sufficient to show saturation.
Nonspecific uptake, determined in the presence of 10 µM
nomifensine, typically accounted for 15-25% of the total
radioactivity bound.

The

Rm

was calculated from the X-

intercept and the Vmax from the slope of the Hanes plot
(s/v vs. s)

(Figure 24, insert).

For the typical control
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Figure 24. Kinetics of Dopamine Uptake into Control Rat
Brain Synaptosomes.

The uptake of dopamine into control synaptosomes was
assayed in triplicate using 10-15 nM ( 3 H]-dopamine and 7
concentrations of unlabelled dopamine ranging from 0-1000
nM .

Nonspecific binding, determined in the presence of 10

µM nomifensine, accounted for 15-25% of the total uptake
detected.

A typical assay is shown.

From the Hanes plot,

which is the substrate concentration/the observed rate
versus the substrate concentration (s/v vs. s)
the control

~

(insert),

(135.7 nM) and the Vmax (8.81 pmole/mg

protein/5 min assay) were determined.

The Chol/PL of

control synaptosomes is 0.440 +/- 0.040 (n

=

11).
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assay shown, the Km was 135.7 nM, and the Vmax was 8.81
pmole/mg protein/5 minute assay.

The Chol/PL of control

synaptosomes was 0.440 +/- 0.040 (n

=

11).

The effect of cholesterol loading on the Km for
dopamine uptake is illustrated in Figure 25.
represents an individual uptake experiment.

Each point
Only assays

with at least 5 data points and a correlation coefficient
of 0.9 or better for the linear fit of the Hanes plot were
included.

As shown in Figure 25, the Km began to sharp-

ly increase as the Chol/PL was increased above 0.5.
Chol/PL above 0.6 are not physiological.

But within the

physiological range of Chol/PL, the increase in Km was
3-fold.

Decreasing the Chol/PL from the control value

produced an approximately 50% decrease in the Km·
The Vmax for uptake showed a similar relationship to Chol/PL (Figure 26).
dividual uptake experiment.

Each point represents an inOnly assays with at least 5

data points and a correlation coefficient of 0.9 or better
for the linear fit of the Hanes plot were included.

At

Chol/PL above 0.5, there was a sharp increase in the
Vmax' reaching a plateau above Chol/PL of 0.6.

Decreas-

ing the Chol/PL produced an approximately 35% decrease in
the Vmax·
The Vmax/Km, a first order rate constant for
the uptake transporter at low substrate concentrations
(Cornish-Bowden, 1979), was calculated for each assay in-
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figure 25. The

Km

for Dopamine Uptake as a Function of

Chol/PL.

oopamine uptake was assayed in cholesterol-depleted,
control, and cholesterol-loaded synaptosomes.

Each assay

consisted of triplicate determinations using 10-15 nM
[3HJ-dopamine and 7 concentrations of unlabelled
dopamine, ranging from 0-1000 nM for control and cholesterol depleted membranes, and 0-5000 nM for cholesterolloaded membranes.

The

Km

was calculated from the

x-intercept of the Hanes plot (s/v vs. s).
represents an individual uptake assay.

Each point

Only assays with at

least 5 concentration points and a correlation coefficient
of 0.9 or better for the linear fit of the Hanes plot were

included.

The Chol/PL of control synaptosomes was 0.440

+/- 0.040 (n

=

11).

Chol/PL of 0.29 to 0.572 could be

considered physiological.

The error bar represents the

mean +/- standard deviation of
Chol/PL.

Km

values at control
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figure 26. The Vmax for Dopamine Uptake as a Function of
Chol/PL.

Dopamine uptake was assayed in cholesterol-depleted,
control, and cholesterol-loaded synaptosomes.

Each assay

consisted of triplicate determinations using 10-15 nM
[3HJ-dopamine and 7 concentrations of unlabelled dopamine
ranging from 0-1000 nM for control and cholesterol-depleted
membranes, and 0-5000 nM for cholesterol-loaded membranes.
The Vmax was calculated from the slope of the Hanes plot
(s/v vs. s).
assay.

Each point represents an individual uptake

Only assays with at least 5 concentration points

and a correlation coefficient of 0.9 or better for the
linear fit of the Hanes plot were included.
control synaptosomes is 0.440 +/- 0.040 (n

The Chol/PL of

=

11).

of 0.29 to 0.572 could be considered physiological.

Chol/PL
The

error bar represents the mean +/- standard deviation of
Vmax values at control Chol/PL.
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eluded in Figures 25 and 26.
Vmaxl~

The relationship between

and Chol/PL is shown in Figure 27.

between 0.5 and 0.7, the
creasing Chol/PL.

Vmaxl~

For Chol/PL

decreased with in-

At Chol/PL below 0.5 and above 0.7,

there was no change in

Vmaxl~

with changes in Chol/PL.

Because the Chol/PL of control SPM and synaptosomes were different, 0.543 +/- 0.014 (n
0.040 (n

=

=

4) and 0.440 +/-

11), respectively, it may be helpful to use the

percent change in Chol/PL to compare the relative microviscosity with the biological effect.

The relative microvis-

cosity of the hydrophobic core increased sharply at a Chol/
PL 10-15% above the control (Figure 28).

As the Chol/PL

was increased 30%, which can be considered the upper limit
of the physiological range of Chol/PL, the relative
microviscosity of the membrane core was about 2-fold
greater than control, while that at the membrane surface
was increased 20%.
Vmaxl~

Over this same range of Chol/PL, the

decreased 33% (Figure 29).

As the Chol/PL was

decreased 40%, the relative microviscosity of the membrane
core decreased 20% while that at the surface decreased
50%.

Little change in the

Vmaxl~

was observed over

this range of Chol/PL.
SUMMARY OF STUDIES WITH RAT WHOLE BRAIN MEMBRANES
Decreasing the Chol/PL produced a decrease in the
relative microviscosity at the surface as well as in the
hydrophobic core.

Because of the sigmoidal relationship
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figure 27. Vmax/Km for Dopamine Uptake as a Function of
Chol/PL

Each point represents the Vmax/Km for dopamine uptake.
The Km and Vmax were calculated from the X-intercept
and slope, respectively, of the Hanes plot (s/v vs. s).
only assays with at least 5 concentration points and a
correlation coefficent of 0.9 or better for the linear fit
of the Hanes plot were included.

The Chol/PL of control

synaptosomes was 0.440 +/- 0.040 (n = 11).

Chol/PL of 0.29

to o.572 could be considered physiological.

The error bar

represents the mean +/- standard deviation of VmaxlI<m
values at control Chol/PL.

FIGURE 27

.151
I
D

.1

I

D

I

E

II

:::('.

I

'--..
x

Do
D

I
I

0

I

E
>

I

'I

I

D

D
0

D

.05

DD

0

Q-+-~~~~....-~~~~,--~~~~.--~~~--.~~~~--.

.2

.4

.6

.8

CHOL/PL

1

1.2
......
rv
(J1

126

Figure 28. The Relative Microviscosity of the Membrane
Surf ace and Hydrophobic Core as a Function of the
Percent Change in Chol/PL.

The relative microviscosity of the membrane surfacn
(ANS,

o )

and core ( DPH,

determined at 37°C.

+/- 0.014 (n = 4).

x ) were calculated from r values

The Chol/PL of control SPM was 0.543

A change in Chol/PL of -50% to 30%

could be considered physiological.

The lines were

generated to fit a theoretical sigmoidal curve that
approximated the experimental data.

Figure 29. Vmaxl!Sn for Dopamine Uptake as a Function of
the Percent Change in Chol/PL.

Each point represents the Vmaxl!Sn for and individual
dopamine uptake assay.

The

ISn

and Vmax were calculated

from the X-intercept and slope, respectively, of the Hanes
plot (s/v vs. s).

Only assays with at least 5 concentra-

tion points and a correlation coefficient of 0.9 or better
for the linear fit of the Hanes plot were included.

The

Chol/PL of control synaptosomes was 0.440 +/- 0.040 (n

11).

A change in Chol/PL of -50% to 30% could be

considered physiological.
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observed, the range of Chol/PL that correlated with the
greatest change in relative microviscosity was near the
physiological Chol/PL.

Decreases in Chol/PL that were

outside the physiological range produced little additional
effect on the relative microviscosity.

An increase in

Chol/PL produced an increase in the relative microviscosity
of both regions of the membrane, although the magnitude of
the increase was greater in the hydrophobic core than at
the membrane surface (Figure 28).
The

Km

for dopamine uptake began to increase

sharply as the Chol/PL was increased, producing a 3-fold
increase within the physiological range of Chol/PL.

At

higher, nonphysiological Chol/PL, the increase was 8- to
10-fold.

Decreasing the Chol/PL, within the physiological

range, produced a 50% decrease in the

Km

(Figure 25).

The Vmax showed a similar relationship to Chol/PL (Figure
26), increasing 3.5-fold as the Chol/PL was increased and
decreasing 35% as the Chol/PL was decreased.

Km

The Vmaxl

was unaffected as the Chol/PL was decreased, but de-

creasee about 33% as the Chol/PL was increased (Figure
27).

At Chol/PL above 0.8, no additional effect was ob-

served in Km, Vmax' or VmaxlI<m·
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DOPAMINE CQ 1 ) BINDING STUDIES USING
BOVINE CAUDATE MEMBRANES
The binding of [ 3 H]-SCH23390 to control, cholesterol-depleted, and cholesterol-loaded bovine caudate
synaptosomes was studied.

Each experimental set of seven

samples included membranes incubated with PC liposomes or
PC-Chol liposomes, using three concentrations of LTP for
each type of liposome.

A control, incubated with sucrose

buffer instead of liposomes, was included with each set.
Before beginning the binding studies, the
SCH-23390 binding assay was optimized in this laboratory.
Because preliminary experiments found the

Ka

to be in the

range of 1 nM, a concentration range of 0.2 to 5.1 nM was
chosen for the kinetic assays.

The optimal membrane pro-

tein concentration was determined to be 300-400 ug protein
per 3 ml assay volume.
A typical binding assay, using control membranes,
is shown in Figure 30.

For control assays, a concentration

range of 0.2 to 5.1 nM SCH23390 was sufficient to show saturation (Figure 30).

Nonspecific binding, determined in

pM

(+)-butaclamol, typically accounted

the presence of 1

for 10-15% of the total radioactivity bound.

The

Ka

was

calculated from the slope, and the Bmax from the Xintercept of the Scatchard plot (bound/free vs. bound)
(Figure 30, insert).
the

Ka

For the typical control assay shown,

was 1.242 nM and the Bmax was 0.261 pmole/mg

protein.
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figure 30. Kinetics of SCH23390 Binding to Control Bovine
Caudate Synaptosomes.

The binding of SCH23390 to control synaptosomes was assayed
in duplicate using 0.2-0.5 nM of [ 3 HJ-SCH23390 and 7
concentrations of unlabelled SCH23390 ranging from 0-5.1
nM.

Nonspecific binding, determined in the presence of 1

µM (+)-butaclamol, accounted for 10-15% of the total
binding.

From the Scatchard plot, bound/free vs. bound

(insert), the control Ka (1.242 nM) and the Bmax (0.261
pmole/mg protein) were determined.

The Chol/PL of control

synaptosomes was 0.556 +/- 0.013 (n

=

8).
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The effect of altering the membrane Chol/PL on the
Kd of SCH23390 binding is illustrated in Figure 31.
point represents an individual binding experiment.

Each
Only

assays with at least 5 data points and a correlation coefficient of 0.9 or better for the linear fit of the Scatchard plot were included.

There appeared to be a trend

toward a decreased Kd as the Chol/PL was increased.

The

change in Kd over the entire range of Chol/PL appeared to
be about 3-fold.
The Bmax for SCH23390 binding, as a function of
Chol/PL, is shown in Figure 32.

Each point represents an

individual binding experiment.

Only assays with at least 5

data points and a correlation coefficient of 0.9 or better
for the linear fit of the Scatchard plot were included.
The Bmax appeared to be independent of Chol/PL.
The Bmax/Kd was calculated for each assay included in Figures 31 and 32.

Its relationship to Chol/PL

is illustrated in Figure 33.

Over the entire range of

Chol/PL, there appeared to be a trend toward an increasing
Bmax/Kd as the Chol/PL was increased.

The magnitude of

this change was about 2-fold.
Although the Chol/PL of control SPM and synaptosomes were not statistically different, 0.542 +/- 0.026 (n

=

4) and 0.556 +/- 0.013 (n

=

8), respectively, it may be

helpful to use the percent change in Chol/PL to compare the
relative microviscosity and the biological effect, in this
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Figure 31. The Kd for SCH23390 Binding to Bovine Caudate
Synaptosomes as a Function of Chol/PL.

scH23390 binding was assayed in cholesterol-depleted,
control, and cholesterol-loaded synaptosomes.

Each assay

consisted of duplicate determinations using 0.2-0.5 nM
[3HJ-SCH23390 and 7 concentrations of unlabelled SCH23390
ranging from 0-5.1 nM.

Ka

The

slope of the Scatchard plot.
individual binding assay.

was calculated from the
Each point represents an

Only assays with at least 5

concentration points and a correlation coefficient of 0.9
or better for the linear fit of the Scatchard plot were
included.

The Chol/PL of control synaptosomes was 0.556

+/- 0.013 (n

=

8).

Chol/PL of 0.30 to 0.723 could be

considered physiological.

The error bar represents the

mean +/- standard deviation of
Chol/PL.

Ka

values at control
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figure 32. The Bmax for SCH23390 Binding to Bovine
Caudate Synaptosomes as a Function of Chol/PL.

scH23390 binding was assayed in cholesterol-depleted,
control, and cholesterol-loaded synaptosomes.

Each assay

consisted of duplicate determinations using 0.2-0.5 nM
[3H]-SCH23390 and 7 concentratiion of unlabelled SCH23390
ranging from 0-5.1 nM.

The Bmax was calculated from the

x-intercept of the Scatchard plot.
an individual binding assay.

Each point represents

Only assays with at least 5

concentration points and a correlation coefficient of 0.9
or better for the linear fit of the Scatchard plot were
included.

The Chol/PL of control synaptosomes was 0.556

+/- 0.013 (n

= 8).

Chol/PL of 0.30 to 0.723 could be

considered physiological.

The error bar represents the

mean +/- standard deviation of Bmax values at control
Chol/PL.
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figure 33. Bmax/Kd for SCH23390 Binding to Bovine
Caudate synaptosomes as a Function of Chol/PL.

Each point represents the Bmax/Kd from an individual
binding assay.

The Kd and Bmax were calculated from

the slope and X-interecept, respectively, of the Scatchard
plot.

Only assays with at least 5 concentration points and

a correlation coefficient of 0.9 or better for the linear
fit of the Scatchard plot were included.
control synaptosmes was 0.556 +/- 0.013 (n

The Chol/PL of

=

8).

Chol/PL

of 0.30 to 0.723 could be considered physiological.

The

error bar represents the mean +/- standard deviation of
Bmax/Kd values at control Chol/PL.
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case the Bmax/Kd for SCH23390 binding.

As the Chol/PL

of the SPM was decreased 30%, there was a decrease in the
relative microviscosity at both the membrane surface and in
the core of the membrane (Figure 34).

This was accompanied

by a trend toward a decreased Bmax/Kd (Figure 35).

As

the Chol/PL was increased 30%, there was little change in
the relative microviscosity of either region of the
membrane (Figure 34).

Also, there was little effect

observed in Bmax/Kd (Figure 35).
DOPAMINE-SENSITIVE ADENYLATE CYCLASE USING
BOVINE CAUDATE MEMBRANES
Additional aliquots of the membranes that were
used to assess the binding of ( 3 H]-SCH23390 were assayed
for dopamine stimulation of adenylate cyclase activity.
Four experimental sets, each including a control, three
cholesterol-depleted, and three
branes, were assayed.

cholesterol-load~d

mem-

For control membranes, the basal

activity was 120.35 +/- 6.45 (n = 4) fmole cAMP formed per
mg protein per 5 minute assay.

The activity stimulated by

100 pM dopamine was 228.57 +/- 4.58 (n = 4) fmole cAMP/mg
protein/5 min.
The basal activity was not strongly affected by
changes in the Chol/PL (Figure 36).

The dopamine-

stimulated activity was not affected when the Chol/PL was
decreased (control Chol/PL= 0.556 +/- 0.013, n

=

8).

However, increasing the Chol/PL produced a decline in the
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Figure 34. The Relative Microviscosity of the Surface and
Hydrophobic Core of Bovine Caudate SPM as a
Function of the Percent Change in Chol/PL.

The relative microviscosity of the membrane surface
(ANS, D) and core (DPH, x) were calculated from r values
determined at 37°c.
o.542 +/- 0.026 (n

The Chol/PL for control SPM was

=

4).

A change in Chol/PL of -50% to

30% could be considered physiological.

Figure 35. Bmax/Kd for SCH23390 Binding to Bovine
Caudate Synaptosomes as a Function of the Percent
Change in Chol/PL

Each point represents the Bmax/Ka for an individual
binding experiment.

The Ka and Bmax were calculated

from the slope and X-intercept, respectively, of the
Scatchard plot.

Only assays with at least 5 concentration

points and a correlation coefficient of 0.9 or better for
the linear fit of the Scatchard plot were included.

The

Chol/PL for control synaptosomes was 0.556 +/- 0.013 (n
8).

=

A change in Chol/PL of -50% to 30% could be considered

physiological.

141

FIGURE 34
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Figure 36. Adenylate Cyclase Activity of Bovine Caudate
Synaptosmes as a Function of Chol/PL

Adenylate cyclase activity was assayed in cholesteroldepleted, control, and cholesterol-loaded synaptosomes.
cyclic AMP was detected by radioimmunoassay.

The

stimulated activity was assayed in the presence of 100 µM
dopamine.

Each point represents the mean and standard

deviation of 4 determinations.

The Chol/PL of control

synaptosomes was 0.556 +/- 0.013 (n

= 8).

Chol/PL of 0.30

to 0.723 could be considered physiological.

Figure 37. Percent Stimulation of Adenylate Cyclase
Activity of Bovine caudate Synaptosomes by
100 µM Dopamine as a Function of Chol/PL.

Adenylate cyclase was assayed as described in Figure 36.
The % stimulation is over the basal activity.

The Chol/PL

of control synaptosomes was 0.556 +/- 0.013 (n

=

8).

PL of 0.30 to 0.723 could be considered physiological.

Chol/
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cAMP formed in the presence of dopamine to a value similar
to the basal level in the absence of dopamine (Figure 36) .
Because the basal activity was largely unchanged, the
percent stimulation by 100 µM dopamine declined as the
Chol/PL was increased to greater than 0.6 (Figure 37).
The percent stimulation of adenylate cyclase activity by 100 µM dopamine as a function of the percent
change in Chol/PL is shown in Figure 38.

Figure 39 shows

the relative microviscosity of the surface (ANS) and hydrophobic core (DPH) of the membrane as a function of the
percent change in Chol/PL.

Although the relative micro-

viscosity decreased as the Chol/PL was decreased 30%
(Figure 39), no effect on dopamine stimulation of adenylate
cyclase activity was detected (Figure 38).

As the Chol/PL

was increased from the control, the very small changes in
relative microviscosity of the membrane (Figure 35) were
accompanied by a dramatic decrease in the stimulation of
adenylate cyclase activity by 100 µM dopamine (Figure 38).
SUMMARY OF STUDIES USING BOVINE CAUDATE MEMBRANES
Decreasing the Chol/PL produced a steady decrease
in the relative microviscosity of the membrane surface and
hydrophobic core.

Only a small increase in microviscosity

was detected as the Chol/PL was increased.

There appeared

to be a trend toward a higher Kd for SCH23390 binding as
the Chol/PL was increased (Figure 31). No change in the
Bmax was detected (Figure 32).

The Bmax/Kd appeared
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Figure 38. The Percent Stimulation of Adenylate Cyclase
Activity in Bovine Caudate Synaptosomes by 100 µM
Dopamine as a Function of the Percent Change in
Chol/PL.

Adenylate cyclase activity was assayed in cholesteroldepleted, control, and cholesterol-loaded synaptosomes.
cyclic AMP was detected by radioimmunoassay.

The

stimulated activity was assayed in the presence of 100 µM
dopamine.

Each point represents the mean and standard

deviation of 4 determinations.

The Chol/PL of control

synaptosomes was 0.556 +/- 0.013 (n

= 8).

A change in

Chol/PL of -50% to 30% could be considered physiological.

Figure 39. The Relative Microviscosity of the Surface and
Hydrophobic Core of Bovine Caudate SPM as a
Function of the Percent Change in Chol/PL.

The relative microviscosity was of the membrane surface
(ANS, O) and core (DPH, X) were calculated from r values
determined at 37°c.
+/- 0.026 (n

=

4).

The Chol/PL of control SPM was 0.542
A change in Chol/PL of -50% to 30%

could be considered physiological.
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to decrease as the Chol/PL was decreased, and to increase
as the Chol/PL was increased (Figure 33).

Basal adenylate

cyclase activity was unaffected by the experimentally
produced changes in Chol/PL (Figure 36).

However, that

stimulated by 100 µM dopamine decreased as the Chol/PL was
increased (Figure 36).

This resulted in a decrease in the

percent stimulation by dopamine as the Chol/PL was
increased (Figure 37).

CHAPTER V
DISCUSSION
The research described in this dissertation examined the influence of the molar ratio of cholesterol to
phospholipid (Chol/PL) on synaptic membrane fluidity, and
on selected membrane-associated functions of the dopaminergic system.

Modification of the synaptic ratio of cho-

lesterol to phospholipid was facilitated by a lipid transfer protein.
uptake,

o1

Alterations in membrane fluidity, dopamine

binding, and dopamine-stimulation of adenylate

cyclase activity were observed over a wide range of Chol/
PL, some of which were beyond the physiological range.
However, significant changes in the dopaminergic system
were also detected within the physiological range of Chol/
PL.
The following discussion will address: 1) the
impact of changes in the synaptic Chol/PL on synaptic membrane fluidity at the surface and core of the membrane; 2)
the impact of changes in the synaptic Chol/PL on the dopaminergic system; and 3) the potential relevance of such
changes within the physiological range to age- and/or
alcohol-related changes in the dopaminergic system.
In the present studies, the relative microviscosity of both the hydrophobic core and the surface of
148
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rat whole brain SPM was affected by changes in Chol/PL in
an unexpected manner.

The relationship appeared to be

sigmoidal, producing the greatest change in the relative
microviscosity within the physiological range (Figures 17
and 19).

These renults suggest that synaptic membranes

from rat exist in two distinct states of microviscosity
which is a function of the Chol/PL.

The transition between

these states occurs over a relatively narrow range of Chol/
PL within the physiological range.

This is supported by

Arrhenius plots of DPH anisotropy (Figure 16) which show
that at the physiological Chol/PL, the membranes appear to
undergo a transition between these states such that at low
temperature, the slope of the plot approaches that obtained
at high Chol/PL, and at high temperature, the slope of the
Arrhenius plot approaches that obtained at low Chol/PL.
The presence of cholesterol-rich domains within
the membrane may be responsible for the mentioned sigmoidal
relationship.

In model membranes, at low Chol/PL (0.25, 20

mole%), there are pure phospholipid domains, and a cholesterol-phospholipid phase.

These domains would be readily

detected by the ANS surface probe due to its preference for
interaction with phosphatidylcholine (Slavik, 1982).

The

DPH probe, in theory, should not detect these two domains
because of its presumed uniform distribution throughout the
membrane.

However, at low Chol/PL, the contribution of

proteins to the DPH anisotropy would be greater that at
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high Chol/PL.

This could account for the independence of

microviscosity on Chol/PL at low values.
As the Chol/PL increases (0.43 to 0.54, 30 to 35
mole%), the pure phospholipid phase is abolished
{Schroeder, 1984).

This is accompanied by an inhibition of

the lateral diffusion of cholesterol (Alecia et al., 1982),
which may indicate a marked decrease in the fluidity of the
membrane.

Also, this transition to the entirely PL-chol

membrane may be accompanied by an overall change in the
packing of the phospholipids within the membrane.

The

range of Chol/PL over which this phenomenon occurs in model
membranes is similar to the Chol/PL at which a marked
change in the relative microviscosity was observed in the
experimental membranes used in the present studies.

At

high Chol/PL (1.0, 50 mole%), the cholesterol would begin
to aggregate, forming irregular structures, such as inverted micelles, in the membrane.
exclude both ANS and DPH.

These structures may

This may explain the indepen-

dence of microviscosity on Chol/PL at high values.
Many membrane-associated synaptic functions are
markedly affected by changes in Chol/PL or changes in
fluidity.

For example, it is known that the activity of

such key synaptic enzymes as Na+-K+-ATPase and ligandstimulated adenylate cyclase are altered by changes in the
fluidity of the membrane (Farias et al., 1975; Alivisatos
et al., 1977; Rimon et al., 1978; Alivisatos et al., 1981;
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Whetten et al., 1983).

In addition, the binding to cholin-

ergic, seritonergic and opiate receptors, and to the GABA
transporter are influenced markedly by membrane cholesterol
(Heron et al., 1980a,b; Heron et al., 1981; Chweh & Leslie,
1982; Crews et al., 1983a; North & Fleischer, 1983b).
Presumably, there is a mechanism by which the
central nervous system (CNS) regulates the Chol/PL within a
narrow range in order to minimize the influence of such
changes on neural function.
the Chol/PL is unknown.

The mechanism of regulation of

However, it is possible that such

regulation involves the synthesis of membrane precursors
and the axonal transport of these precursors between the
cell body and the nerve terminal. Since there is a blood
brain barrier to plasma lipoproteins which transport cholesterol and phospholipids throughout the rest of the body
(concepts reviewed by Ochs, 1981, and Katzman, 1981, in
Basic Neurochemistry, Chapters 22 and 25, respectively),
such a barrier may serve to protect the brain and synaptic
membranes from marked changes in plasma lipid levels.
It is interesting that more marked changes in
Chol/PL are seen in membranes outside the blood brain
barrier in response to changes in serum levels of cholesterol and phospholipids.

For example, the lipid compo-

sition of erythrocyte membranes is more susceptible to
changes in serum cholesterol levels than is the lipid
composition of synaptic membranes (Chin et al., 1978).
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Although the functions associated with peripheral membranes
are important, it may be more essential to the short-term
survival of the animal to more finely control the environment of those functions associated with CNS neural membranes.
In the present studies, the modification of
synaptic Chol/PL was found to have a marked effect on the
uptake of dopamine.

The

~

for dopamine uptake into rat

whole brain synaptosomes increased sharply as the Chol/PL
was increased (Figure 25).

An increase in Chol/PL of 30%

produced a 3-fold increase in the

~

(Figure 25) .

over

the same range of Chol/PL, there was a small increase in
the Vmax (Figure 26).

These results suggest that as the

membrane becomes more rigid, the affinity of the uptake
transporter for dopamine decreases.

At the same time,

there is a partially compensatory increase in the maximum
velocity.

However, although the Vmax was increased, a

higher concentration of dopamine would be required to
achieve this maximum rate, due to the increase in
should be noted that the increase in

~

~·

It

occurs within the

range of Chol/PL that produced the dramatic change in the
relative microviscosity.
At first glance, the increase in both the
the Vmax appears unusual.
easily in kinetic terms.
uptake process:

~

and

However, this is explained
For the simplest scheme for the
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k1,
T + dopamine 0 ut;====-

k2

T·dopamine~~~)

T + dopaminein

k_l
the

Km = k2

+ k_l

and the vmax

= k2

[T],

k1
with T representing the uptake transporter.

Because in the

in vitro assay the concentration of the transporter is
constant, the increase in the Vmax would be due to an
increase in k 2 .

This increase in k 2 will also produce

Km·

an increase in

Perhaps a more useful index of dopamine uptake is
the Vmax/Km (Figure 27), a first order rate constant
for the uptake transporter at low substrate concentrations.

At synaptic concentrations of dopamine that are

less than the

Km,

by the VmaxlI<m·
than the

Km,

the rate of uptake will be determined
At concentrations that are greater

the rate of uptake will be determined by the

Vmax (Cornish-Bowden, 1979).
As the Chol/PL was increased 30% (within the
physiological range), there was a 33% decrease in the
VmaxlI<m·

This suggests that as the membrane becomes

more rigid, the rate of uptake will decrease if the
synaptic concentration of dopamine is less than the

Km·

Because the concentration of dopamine in the synapse in not
known, an absolute statement as to the expected effect of
changes in Chol/PL on in vivo dopamine uptake are not
possible.
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Since synaptic uptake of dopamine must, by def inition, involve a transmembrane process, it is not surprising
that the uptake would be sensitive to changes in the membrane environment of the transporter.

Although the mechan-

ism of the dopamine uptake process into synaptosomes is not
known, it is presumably similar to the uptake of the other
biogenic amines.

Kinetic studies suggest that the trans-

port of norepinephrine into synaptosomes is protein-mediated and coupled to the transport of Na+ (Trendelenburg,
1981).

Such a transmembrane transport protein must have

certain structural features in order to function eff iciently (Carruthers & Melchior, 1986).

The protein must

contain domains that catalyze the unidirectional transfer
of substrates across the lipid bilayer.

These domains

could be a series of gates that are triggered as the substrate moves through the protein.

Alternately, the domains

may form a channel through the protein, through which substrates may pass.

The transporter must also contain sub-

strate recognition sites.

These sites would initiate the

gating mechanism or open the transport channel when the
substrate is bound.
present.

Also, regulatory domains might be

Each of these domains, and the coupling between

these domains could be modulated by changes in the lipid
environment (Carruthers & Melchior, 1986).

It is possible

that the dopamine uptake transporter is within one of the
pure phospholipid regions of the membrane.

As the Chol/PL
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increases, and the phospholipid domain is abolished, the
uptake may be inhibited, due to the accompanying increase
in the membrane microviscosity.

Also, the rate of dopamine

uptake would be dependent on the sodium gradient across the
synaptic membrane.

At low Chol/PL, the membrane may be

more permeable to sodium ions, dissipating the gradient and
slowing the rate of uptake.

At high Chol/PL, the membrane

may become less permeable to sodium ions, resulting in a
greater potential difference across the membrane, increasing the uptake rate.
The present studies suggest that there is a small
influence of Chol/PL and membrane fluidity on the binding
of SCH23390 to the
branes.

o1

receptor in bovine caudate mem-

over the range of Chol/PL of 0.3 to 0.5, there was

an decrease in the Ka for SCH23390 of about 50% (Figure
31).

Because the Bmax was unchanged (Figure 32), the

Bmax/Ka tended to decrease as the Chol/PL decreased
over this range.

At Chol/PL above 0.5, the o1 receptor

appears to be unaffected.
Dopamine-stimulated adenylate cyclase is a membrane-associated enzyme whose activity is stimulated
through a multi-step process, initiated by the binding of
dopamine to the

o 1 receptor.

The activation of adenylate

cyclase requires the lateral diffusion of the receptor, as
well as the regulatory G-protein (Rimon et al., 1978).
This type of mechanism would be expected to be affected by
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changes in membrane fluidity.
The present studies examined the effects of altering the Chol/PL of bovine caudate synaptosomal membranes on
basal and dopamine-stimulated adenylate cyclase activity.
These studies demonstrated that the activity of dopaminestimulated adenylated cyclase was modulated by the synaptic
Chol/PL.

If the dopamine receptor system is coupled to

adenylate cyclase through a mobile receptor, as is epinephrine (Rimon et al., 1978), decreasing the relative microviscosity of the membrane would be expected to enhance the
stimulatory effect of the ligand (Rimon et al., 1978).

The

dopamine stimulation of adenylate cyclase activity was not
affected by decreasing the membrane fluidity via decreasing
the Chol/PL (Figures 38 and 39).

The discrepancy of the

present results with those expected of a mobile receptor
may be due to the masking of the effect by maximally stimulating the enzyme.

Cholesterol loading of the synaptic

membranes produced a marked inhibition of maximal dopamine
stimulation of adenylate cyclase activity (Figure 36) .
Because of the lateral movement of the G-protein required
for activation of the enzyme, the dopamine-stimulated
adenylate cyclase system may require a more fluid phospholipid domain for optimal stimulation.

When the phospho-

lipid domain is abolished by increasing the Chol/PL, the
stimulated activity may be expected to decrease.

The basal

activity was unaffected by changes in membrane composition
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and fluidity (Figure 36).
The results of the present studies have demonstrated that the transmembrane processes involved with the
dopaminergic system, namely, the uptake of dopamine and
dopamine stimulation of adenylate cyclase, are inhibited by
an increase in Chol/PL.

Since aging and alcohol are known

to be associated with an increase in synaptic Chol/PL (Chin
et al., 1978; Smith & Gerhart, 1982; Armbrecht et al.,
1983; Crews et al., 1983b; Shinitzky et al., 1983), some of
the dopaminergic changes which are found in these conditions may be due to increases in Chol/PL.
appear to be unrelated.

Other changes

Specific examples of the potential

contribution of the change in Chol/PL to age- and/or
alcohol-associated changes in dopaminergic function are
discussed.
The change in dopamine uptake with normal postnatal development as well as with aging may be explained,
in part, by normal physiological changes in Chol/PL.
During postnatal development, there is an increase in
dopamine uptake, due to an increase in the Vmax (Coyle &
Campachiaro, 1976).

In the present studies, as the Chol/PL

was decreased from the normal adult ratio to that found in
the synaptic membranes from young animals, the Vmax
decreased (Figure 26).

This suggests that the increased

Vmax for dopamine uptake, which occurs during development
may be due to an increase in the number of uptake trans-
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porters per cell rather than to changes in membrane composition and fluidity.
Studies of the effects of aging on dopamine uptake
(Jonec & Finch, 1975) showed a 30% decrease in dopamine
uptake at a dopamine concentration of 10 nM, which is below
the

~

(40 nM).

This decrease was attributed to a 35%

increase in the ~·
observed, the

Vmaxl~

Because no change in Vmax was
was decreased with aging.

As

would be expected, at 120 nM, which is above the

~'

no

difference was observed between the young and old animals.
The increased

~

for dopamine uptake observed in the

present studies as the Chol/PL was increased suggests that
the changes in Chol/PL and membrane fluidity which occur
during aging may be responsible, in part, for the observed
changes in dopamine uptake.
In addition, it appears that the age- and/or
alcohol-related changes in dopamine stimulation of adenylate cyclase activity may be related to changes in the
Chol/PL.

During aging (Puri & Volicer, 1977; Makman et

al., 1980; Schmidt & Thornberry, 1981) and with chronic
ethanol treatment (Tabakoff & Hoffman, 1979; Lucchi et al.,
1983), there was a decreased sensitivity of adenylate
cyclase for dopamine, due to a decreased efficiency of
coupling between the receptor and the catalytic site of
adenylate cyclase (Tabakoff & Hoffman, 1979).

The present

studies suggest that this decreased sensitivity could be
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due to age- and/or alcohol-related membrane fluidity
changes.
It is difficult to correlate the present studies
with the current literature on dopamine receptors in developing, aging, and ethanol-treated animals.

Past studies

have generally used the radioactive ligand,

[ 3 H]-spiper-

one, to label dopamine receptors.

However, depending on

the concentration of spiperone, the assay conditions, and
the brain region analyzed, spiperone can label o1 , o2 ,
and serotonin receptors.

There is indirect evidence, from

studies using spiperone and a o2 specific ligand, that
the decrease in the Bmax for spiperone binding detected
in aged animals, may be due to the o 1 receptors (Memo et
al., 1980; Severson & Finch, 1980; Trabucchi et al., 1982;
Missale et al., 1983).
of the

o1

In the present studies, the Bmax

receptor, as assessed using SCH23390, was un-

affected by changes in membrane fluidity.

Therefore, if

the decrease in the Bmax detected in aged animals is due
to the o1 receptors, it is unlikely that this decrease is
due to membrane fluidity effects.
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SUMMARY
The research described in this dissertation
examined the influence of the cholesterol to phospholipid
molar ratio on synaptic membrane fluidity, and on selected
membrane-associated functions of the dopaminergic system.
Modifications of the synaptic cholesterol to phospholipid
molar ratio was facilitated by a lipid transfer protein.
synaptic membrane fluidity was assessed using l-anilinonaphthalene-8-sulfonic acid (ANS) and l,6-diphenyl-1,3,5hexatriene (DPH) as probes of membrane surface and core
fluidity, respectively.

The components of dopaminergic

function which were assessed include dopamine uptake, o 1
binding, and

o1 -stimulated

adenylate cyclase activity.

Alterations in membrane fluidity, dopamine uptake,

o1

binding and dopamine stimulation of adenylate cyclase
activity were observed over a wide range of Chol/PL, some
of which were beyond the physiological range.

However,

significant changes in the dopaminergic system were also
detected within the physiological range of Chol/PL.
The results of the studies described in this
dissertation suggest that the transmembrane processes of
the dopaminergic system, dopamine uptake and dopaminestimulated adenylate cyclase activity, are highly sensitive
to changes in the Chol/PL of synaptic and synaptosomal membranes within the physiological range of Chol/PL.

For

example, as the fluidity of the membrane was decreased by
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increasing the Chol/PL 30% above the normal value, the ~
for dopamine uptake was increased 3-fold.
also caused a 33% decrease in the

Vmax/~,

such an increase
the first

order rate constant for dopamine uptake at low concentrations of dopamine.

In addition, cholesterol loading of the

synaptic membranes produced a marked inhibition (80-90%) of
the maximal stimulation of adenylate cyclase by dopamine.
In contrast to the highly sensitive transmembrane processes
of the dopaminergic system, D1 binding was less sensitive
to the effects of changes in membrane Chol/PL and fluidity.

As the Chol/PL was increased 33% above the control

value, the binding of SCH23390 to the

o1 site was un-

affected.
In light of the findings presented here, it
appears likely that some of the changes in dopaminergic
function which are known to accompany aging and chronic
alcohol consumption can be explained by the age- and
alcohol-associated changes in the synaptic Chol/PL and
fluidity.

In particular, it seems likely that the age-

associated decrease in

Vmaxl~

for uptake and decreased

sensitivity of adenylate cyclase for dopamine could be
related to the increased Chol/PL in those animals.

The

decreased efficiency of coupling of the dopamine receptor
with the catalytic site of adenylate cyclase in alcoholtreated animals might similarly be explained.

These

observations are consistent with reports from other lab-
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oratories of cholesterol inhibition of diffusion-controlled
enzyme systems.

In contrast, it does not seem likely that

altered synaptic Chol/PL and fluidity contribute significantly to physiological changes in D1 binding.
The results presented here provide significant new
information about how synaptic membrane composition and
fluidity affect synaptic function.

In addition, this new

information may contribute to our understanding of the
causes of age- and alcohol-associated changes in CNS
function.
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